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Zusammenfassung 
Das Wilms Tumorsuppressorprotein 1, WT1, ist ein Zink-Finger Transkriptionsfaktor, der 
eine essentielle Rolle in der Entwicklung von Herz, Gonaden, Nieren und anderen Organen 
spielt. WT1-Mutationen stehen im Zusammenhang mit verschiedenen Erkrankungen des 
Menschen. Dazu gehören Wilms Tumorerkrankungen, das Denys-Drash- und das Frasier-
Syndrom. Wilms Tumore gehören zu den häufigsten Nierentumoren bei Kindern. Die 
beiden genannten Syndrome sind gekennzeichnet durch urogenitale Fehlbildungen und 
den Verlust der Nierenfunktion. In Säugetieren wird Wt1 während der gesamten 
Nierenentwicklung exprimiert und ist vor allem für die Einleitung der Nierenentwicklung 
von besonderer Bedeutung. Wt1-knock-out-Mäuse bilden keine Nieren und sterben, 
vermutlich aufgrund von Herzfehlern, kurz vor der Geburt. In der adulten Niere ist die 
Expression von Wt1 begrenzt auf eine einzige Zellpopulation. Hierbei handelt es sich um 
die Podozyten, welche einen Hauptbestandteil des renalen Filtrationsapparates darstellen. 
Podozytendefekte führen zu schweren Nierenfunktionsstörungen. Im Rahmen dieser 
Arbeit wurde ein konditionales Wt1-knock-out-Mausmodell generiert, das es ermöglicht, 
Wt1 ausschließlich in Podozyten-Vorläuferzellen der sich entwickelnden Niere zu 
inaktivieren. Entsprechende Mäuse starben spätestens 24 Stunden nach der Geburt; 
Harnausscheidung war zu keinem Zeitpunkt nachweisbar (Anurie). Zudem konnte eine 
signifikante Reduktion der Nierenkörperchen (Glomeruli) in neugeborenen Mäusen mit 
podozyten-spezifischer Wt1 Inaktivierung festgestellt werden. Die Nierenkörperchen, in 
denen unter anderem auch die Podozyten lokalisiert sind, sind verantwortlich für die 
Ultrafiltration des Blutes und somit für die Primärharnbildung. Mithilfe 
elektronenmikroskopischer Untersuchungen an noch vorhandenen Nierenkörperchen 
konnte gezeigt werden, dass Podozyten starken strukturellen Veränderungen unterworfen 
waren. Dies führte zum Verlust von für die Filtrationsfunktion der Niere essentiellen 
Strukturen, den sogennannten Fußfortsätzen. Außerdem war eine ausgeprägte 
Degeneration der proximalen Tubuli evident. Aus diesen Befunden läßt sich 
schlussfolgern, dass Wt1 ein wichtiger Faktor für die Entwicklung und Funktion von 
Podozyten ist. Wt1-Deletion in sich entwickelnden Podozyten führt demnach zur 
Degeneration dieser Zellpopulation und dies wiederum zum Verlust der Nierenfunktion. 
Ein weiteres Ziel dieser Arbeit war es, die Rolle von Wt1 in der Erhaltung und Funktion der 
Podozyten in adulten Mäusen zu untersuchen. Zu diesem Zweck wurde ein System 
angewendet, mit dem die Inaktivierung von Wt1 über die Applikation des Antibiotikums 
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Doxyzyklin induziert werden kann. Podozyten-begrenzte Wt1-Deletion in adulten Mäusen 
führte zur Ausscheidung hoher Proteinmengen mit dem Urin (Proteinurie). Die Podozyten 
dieser Tiere wiesen eine starke Reduktion der Fußfortsätze auf. Letzteres war vermutlich 
die Ursache für die Proteinurie. Die Tiere waren über einen kurzen Zeitraum lebensfähig. 
Nach viermonatiger Doxyzyklin-Behandlung jedoch starben zwei von drei Tieren. Diese 
Studie konnte demnach zum ersten Mal belegen, dass Wt1 auch für die Erhaltung und 
funktionelle Integrität der Podozyten in adulten Tieren essentiell ist. 
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Abstract 
The Wilms tumor suppressor protein 1 Wt1 is a zinc-finger transcription factor and 
essential for the development of several organs including heart, gonads and kidneys. WT1 
mutations are associated with a variety of human diseases such as Wilms tumor, a frequent 
pediatric kidney cancer, as well as Denys-Drash and Frasier syndrome. The latter are 
characterized by genitourinary malformations and impairment of kidney function. In 
mammals Wt1 is expressed throughout all stages of kidney development and is specifically 
required for the onset of kidney formation. Wt1 knock-out mice do not form kidneys and 
die shortly before birth, most probably due to heart failure. In the adult kidney Wt1 is 
restricted to a single cell population termed podocytes. This particular cell type forms a 
major part of the renal filtration barrier. Podocyte defects result in severe kidney 
malfunction. In this work a conditional knock-out mouse model was generated allowing 
the deletion of Wt1 specifically in podocyte precursor cells of the developing kidney. Mice 
with podocyte-specific Wt1 inactivation died 24 hours after birth and showed no signs of 
urine production (anuria). The number of glomeruli, being the basic filtration units of the 
kidney, was significantly reduced in newborn animals due to enhanced apoptosis. Electron 
microscopic analyses of remaining glomeruli revealed the degeneration of podocyte 
structures (foot-processes) essential for the renal filtration capacity. In addition, proximal 
tubuli were degenerated to a great extent. Thus, Wt1 is important for podocyte 
development and functionality. Degeneration of developing podocytes as a consequence 
of Wt1 inactivation leads to the loss of integral parts of the renal filtration apparatus and to 
loss of kidney function. 
To assess the role of Wt1 in the maintenance of podocyte and kidney function a system 
was used whereby Wt1 deletion can be induced by administration of the drug doxycycline. 
Podocyte restricted inactivation of the gene in adult mice resulted in severe proteinuria, 
which was accompanied by a significant reduction in the number of foot-processes. In 
most cases mice were viable over a short period of time. After four months of continuous 
doxycycline treatment, however, two out of three mice had died. In this study it was 
demonstrated for the first time that Wt1 is essential for the maintenance and functional 
integrity of podocytes in adult mice.  
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Fig. 1 Wt1 – mRNA (A) and protein structure (B). Wt1 mRNA consists of 10 exons. Two major alternative 
splicing events affect exon 5 (splice I), which codes for 17 amino acids in the central part of the protein and 
a 9 bp sequence at the end of exon 9 (splice II) encoding amino acids lysine (K), threonine (T) and serine (S) 
between zinc fingers 3 and 4. The protein harbors a N-terminal proline/glutamine rich trans-activation 
domain and a zinc-finger domain at its C-terminus. (Modified from Englert, 1998)  
1 Introduction 
1.1 WT1 
The Wilms tumor suppressor gene, WT1, was identified in a search for the genetic causes of 
Wilms Tumor, a frequent pediatric kidney cancer with an incidence of 1 in 10,000 children 
in North America1, 2. WT1 was found to be inactivated in 10-15 % of cases3, 4. The human 
gene maps to chromosome 11p13 (REF. 2) and spans about 50 kb of genomic DNA 
encompassing 10 exons (Fig. 1 A)5, 6. It encodes a protein family of at least 24 different 
isoforms derived from alternative splicing, usage of alternative translation starts and RNA-
editing. The major characteristics of WT1 proteins are those of typical transcription factors: 
they harbor a N-terminal proline/glutamine-rich transactivation domain and four C-
terminal zinc fingers of the Cys2-His2 type (Fig. 1 B). Each zinc finger is encoded by a 
separate exon, exons 7-10; the transactivation domain is encoded by exon 1 alone6, 7. 
 
The four most abundant WT1 isoforms are derived from two alternative splicing events 
(Fig. 1 A, B): the first affects the mammalian specific exon 5, which codes for 17 amino acids 
located between transactivation and zinc finger domain6, 8. The functional properties of 
this amino acid sequence have not yet been determined; specific deletion, however, has 
no obvious pathological consequences in mice9. The second alternative splicing event 
gives rise to functionally very different WT1 isoforms. Alternative inclusion or omission of a 
9 bp sequence at the end of exon 9 results in protein variants either containing or lacking 
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the three amino acids lysine (K), threonine (T) and serine (S) between zinc finger domains 3 
and 4 (REF. 6). Corresponding isoforms are termed WT1(+KTS) and WT1(-KTS) and are 
expressed in a constant ratio of about 2:1 in humans6.  
The WT1(-KTS) isoform has been extensively studied and proven to act mainly as 
transcription factor with either activating or repressive function depending on the target 
gene10-12. In table 1 examples of proposed WT1 target genes are listed.  
Since insertion of the KTS sequence negatively influences DNA binding capability13, 14, the 
WT1(+KTS) variant was thought to fulfill other functions. As a matter of fact, WT1(+KTS) 
isoforms colocalize and interact with splice factors and pre-mRNA15, 16. This has provoked 
the assumption that it might be involved in RNA processing. Though, direct evidence is still 
not available. 
Table 1 Wt1 target genes 
Target Gene Gene product Activation/Repression Reference 
EGR-1 Early growth response protein 1 Repression 17 
TGF-β1 Transforming growth factor beta 1 Repression 18 
IGF-2 Insulin-like growth factor 2 Repression 19 
Areg Amphiregulin Activation 20 
Podxl Podocalyxin Activation 21 
Nphs1 Nephrin Activation 22 
Pax-2 Paired box protein 2 Repression 23 
Sry Sex determining region of chr. Y Activation 24 
PDGF-A Platelet-derived growth factor A Repression 25 
VEGF Vascular endothelial growth factor Activation 26 
 
WT1 mutations are not only relevant for the formation of Wilms tumor, but also account for 
a number of other human diseases. One example is the WAGR (Wilms tumor, aniridia, 
genitourinary malformations, mental retardation) syndrome. It results from chromosomal 
deletions at locus 11p13 that encompass WT1 and PAX6, among others27-29. PAX6, being a 
master regulator of eye development, is likely to cause the aniridia phenotype. Reduction 
in WT1 gene dosage on the other hand is held responsible for the genitourinary 
malformations and predisposition to Wilms Tumor. WAGR patients with point mutations in 
the remaining WT1 allele of renal precursor cells have a high risk to develop Wilms tumor30, 
31. 
Another syndrome associated with WT1 mutations is the Denys-Drash syndrome (DDS). It 
is characterized by severe urogenital defects, such as nephropathy and gonadal dysgenesis 
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with male pseudohermaphroditism. Furthermore, 70 – 80 % of DDS-patients develop 
Wilms tumor. DDS is caused by missense mutations in a WT1 allele. The most common 
mutation results in an arginine to tryptophane conversion at position 394 within the third 
zinc finger32-35. DNA binding capability of WT1 is hereby abrogated. Considering the 
severity of the developmental defects and the unusually high incidence of Wilms tumor a 
dominant-negative effect of the mutation seems likely, especially, since WT1 normally 
functions by formation of homodimers through N-terminal interaction. Association of 
defective and wild-type protein might thus aggravate the effect36-39. 
Frasier syndrome (FS) is associated with male-to-female sex reversal and renal anomalies 
including glomerulopathy. However, patients show no pre-disposition to Wilms tumor. FS 
is a consequence of a heterozygous point mutation in the alternative donor splice site in 
intron 9, which leads to the loss of WT1(+KTS) expression from the affected allele and, 
hence, to a change in the WT1(+KTS)/WT1(-KTS) ratio40, 41. That a constant ratio of these 
WT1 isoforms is indispensable for proper development, especially of the renal and genital 
system, has been emphasized in a mouse model: mice expressing both Wt1 isoforms from 
the wildtype allele, but only Wt1(-KTS) from the other develop renal dysfunctions 
comparable to those observed in human FS patients. Animals with total loss of Wt1(+KTS) 
expression show complete male-to-female sex reversal and severe kidney defects. 
Specific inactivation of the Wt1(–KTS) isoform results in reduced kidney size and 
glomerular number, as well as retarded gonad development. Both total Wt1(+KTS) and 
Wt1(–KTS) knock-out mice die shortly after birth42, 43.  
Somatic WT1 mutations have also been detected in acute myeloid leukemia (AML)44, DDS-
associated gonadoblastoma32 and very rare cases of mesotheliomas45. All this has 
underlined the now widely accepted hypothesis that WT1 functions as tumor suppressor. 
However, growing evidence supports the possibility that, under certain conditions, WT1 
also acts as oncogene: in a number of adult tumors, including colorectal46, desmoid47, 
breast48 and brain49 tumors it is ectopically expressed and exhibits no mutations. Along this 
line, over-expression of wild-type, non-mutated WT1 in some leukemias accounts for a 
poor prognosis50, 51. 
Studies of human syndromes and mouse models have revealed an essential role of WT1 in 
the development of kidneys and gonads. But, as learned from mice, Wt1 expression is not 
at all restricted to the urogenital system. On the contrary, Wt1 is found to be expressed in 
and relevant for a wealth of other developing organs and tissues. This includes spleen, 
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spinal cord, brain, retina, adrenal glands, hematopoietic system, olfactory system and 
mesothelial tissue lining heart, diaphragm, liver and gut52-58. Insight into Wt1 function in 
most of the mentioned tissues and organs has been gained predominantly by the study of 
conventional Wt1 knock-out mice59. In contrast to human patients, heterozygous 
inactivation of Wt1 has no pathological implications in mice. Instead, Wt1-/- animals die in 
utero between embryonic day E13.0 and E15.0, presumably due to malformations of heart 
and/or diaphragm. Kidney and gonad development commences, but ceases rapidly by 
apoptosis of renal and gonadal progenitor cells resulting in agenesis of both organs.  
1.2 The mammalian kidney – Structure and function 
In mammals the metanephros, or permanent kidney, is the major excretory and 
homeostatic organ. It performs two essential functions: first, metabolic end products, such 
as urea and ammonium are removed from the blood through passive filtration. Second, 
electrolyte concentration and pH of the body fluid are controlled through modifications of 
the ultrafiltrate, or primary urine. Moreover, the kidney is involved in blood pressure 
regulation via excretion or retention of salt and water leading to changes in blood volume 
and pressure. The enzyme renin is released from the kidneys in case of low blood pressure. 
It activates the renin-angiotensin-aldosterone system, which ultimately results in the 
elevation of blood pressure levels. Another important property of the kidney is the 
production of the hormone erythropoietin (Epo), which is essential for the control of red 
blood cell production, or erythropoiesis.60 
The adult mammalian kidney is of bean-shape with a superior and an inferior pole. Its 
parenchyma can be grossly divided into a cortex and medulla. The basic structural and 
functional unit, the nephron, draws through both parts (Fig. 2). All essential kidney 
functions from blood filtration to re-absorption of salt and water are performed by the 
latter structure. Each adult human kidney contains 300.000 to 1.200.000 nephrons; in the 
mouse between 8.000 and 12.000 nephrons are present per kidney.60  
The nephron consists basically of two parts, the renal corpuscle, or glomerulus, and the 
renal tubule. The renal corpuscle is formed by the Bowman’s capsule, being the expanded 
proximal end of the nephron, and the capillary (vascular) tuft, which invades the Bowman’s 
capsule. Afferent and efferent arterioles enter and exit at the capsule’s vascular pole. At the 
opposite end, termed the urinary pole, the Bowman’s capsule is connected to the renal 
tubule. The renal tubule itself is structured into the proximal tubule, with a convoluted part 
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directly extending from the Bowman’s capsule, and a straight part, the loop of Henle and 
the distal tubule, including a straight and convoluted compartment. The connecting 
segment connects the nephron with the collecting duct (Fig. 2).61  
Glomeruli, convoluted parts of proximal and distal tubules, as well as connecting segments 
are located within the renal cortex. The medulla contains the loop of Henle, the collecting 
ducts and most parts of the straight proximal and distal tubules.61 
 
Blood filtration takes place in the glomerulus. The filtration barrier is constituted essentially 
of three components: endothelial cells of the capillary tuft, a glomerular basement 
membrane (GBM) and the so called slit diaphragm formed by highly specialized cells of the 
visceral epithelial layer of the Bowman’s capsule (Fig. 3 A, B). Glomerular endothelial cells 
are highly fenestrated, but do not have diaphragms. They serve as a barrier for cellular, but 
not sub-cellular components of the blood. Visceral epithelial cells, also termed podocytes, 
form long primary processes that entwine around glomerular capillary vessels. By 
extension of interdigitating secondary processes, the so called foot processes, the 
glomerular endothelium is entirely enwrapped and covered by podocytes. Interdigitating 
foot processes of neighboring primary processes are separated by a narrow filtration slit, 
which is bridged by a filamentous sheet referred to as the slit diaphragm (Fig. 3 A, B). The 
latter structure functions as efficient barrier for macromolecules exhibiting diameters 
larger than 8.0 nm. Endothelial and podocyte layer are separated from each other by the 
Fig. 2 Gross anatomy of the adult kidney. The kidney can roughly be divided into cortex and medulla. 
The major functional unit, the nephron, consists of the glomerulus with vascular tuft, proximal and distal 
tubules and the loop of Henle. Collecting ducts transport the urine to the renal pelvis, which is connected 
to the ureter. (Modified from Schedl, 2007)  
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glomerular basement membrane (GBM). It results from fusion of the basal laminae of both 
cell layers and forms a tight meshwork consisting predominantly of type IV collagen fibrils. 
Apart from being a mechanical filter excluding molecules larger than albumin (~69 kDa), 
the glomerular filtration barrier also has charge selective properties. Many of its 
components, including the GBM, are negatively charged and therefore repel most plasma 
proteins.60-62  
 
Another cell population present in the glomerulus is no component of the filtration barrier, 
but has important structural functions: masangial cells are found in between glomerular 
capillaries. They form a tight mesangial matrix and are essential for maintaining the 
structural integrity of the glomerulus against strong hydrostatic forces within capillary 
vessels.60, 61 
The outer surface of the Bowman’s capsule is constituted by the pariethal epithelium, 
consisting of simple epithelial cells (pariethal epithelial cells, PEC). It is continuous with the 
visceral epithelium formed by podocytes. Both layers are separated by the Bowman’s 
space into which the ultrafiltrate is forced. From there it is drained into the proximal 
convoluted tubule. The entire proximal tubule accounts for most reabsorption of proteins, 
amino acids, glucose, creatinin, water and Cl- as well as Na+ ions. After further modifications 
in the remaining tubular sections, the filtrate is finally released from the kidney as highly 
concentrated urine.61 
Fig. 3 Structure of Podocytes (A) and glomerular filtration barrier (B). Podocytes (or visceral epithelial 
cells) are characterized by long primary (P) and interdigitating secondary processes, or foot processes (FP), 
that completely enwrap glomerular capillary vessels. The space between interdigitating foot processes is 
bridged by the slit diaphragm (SD). Podocyte cell layer and endothelium (ET) are connected via the 
glomerular basement membrane (GBM). Together, podocytes, slit diaphragm, GBM and endothelium 
constitute the glomerular filtration barrier. (Modified from Pavenstädt et al., 2003) 
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1.3 Kidney development and Wt1 
The mammalian kidney develops from an epithelial component, namely the primary 
nephric duct or Wolffian duct, and a mesenchymal component, the metanephric blastema. 
Both derive from the intermediate mesoderm. For kidney development to commence 
reciprocal interactions between the two components are required63. Initially, the 
metanephric blastema is specified as renal precursor by processes involving transcription 
factors odd skipped related 1 (Osr1)64, 65, paired-box proteins Pax2 and 8 (REF. 66), and eyes 
absent homologue 1 (Eya1)67. At around embryonic day E10.5 in mice (week 5 to 6 of 
gestation in humans) the specified metanephric blastema induces the primary nephric 
duct to form an outgrowth, the ureteric bud. This structure invades the blastema and 
undergoes branching morphogenesis. At the tips of newly formed branches adjacent 
mesenchymal cells are induced to aggregate and thereby form a cap structure. A 
proportion of these cells begins the process of mesenchymal-to-epithelial transition, 
resulting in the formation of the renal vesicle. Another proportion generates the interstitial 
stroma. As it progresses, the 
renal vesicle gradually 
forms two distinct clefts 
giving rise to the comma-
shaped and S-shaped body, 
respectively. The S-shaped 
body further elongates and 
differentiates into the 
various segments of the 
nephron. On its distal end it 
fuses with the ureteric duct 
to form a continuous lumen. At the proximal end the glomerulus develops: signals 
released from podocyte precursor cells attract endothelial cells to invade and to form the 
vascular tuft. In turn, endothelial cells produce factors that support mesangial cell 
differentiation. At this stage, termed capillary loop stage, components of the renal filtration 
barrier begin to arise. Podocyte precursors start to form foot processes as well as slit 
diaphragms. Also, the glomerular basement membrane (GBM) takes shape. By embryonic 
day E15.5 maturing nephrons harboring all functionally relevant components and 
Fig. 4 Kidney and nephron 
development. At E15.5 nephrons 
of different developmental stages 
are present in the kidney. (1) 
Nephron development starts with 
condensing mesenchymal cells at 
ureteric tips. (2) The renal vesicle 
results from mesenchymal-to-
epithelial transition. (3) Comma-
shaped body. (4) S-shaped body. 
(5) Mature nephron with 
glomerulus and tubules. Nephron 
development is a continous 
process, progressing from outer to 
inner cortex. (Modified from 
Schedl, 2007)  
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structures can be observed in the embryonic kidney. The still extending and branching 
ureteric duct has by now formed a major part of the collecting duct system (Fig. 4)63, 68, 69. 
Kidney size is primarily defined by the overall number of nephrons generated during 
development. As described, nephron formation is a continuous process driven by ongoing 
ureteric duct branching. New nephrons are added at the outermost cortex, where 
undifferentiated mesenchymal precursor cells are located. The most advanced or 
differentiated nephrons thus reside close to the medulla in the innermost cortex. In 
humans kidney development is completed with birth. In mice, however, it continues for 
about 1 week after birth70. 
Wt1 is highly expressed in condensing mesenchymal cells in the outer cortex (nephrogenic 
zone), in podocyte precursor cells of comma- and S-shaped bodies, and in fully 
differentiated podocytes11. In concordance with this expression pattern Wt1 has important 
functions in various stages of kidney development.  
Essential for the first step in nephrogenesis, the induction of ureteric bud outgrowth, is the 
secretion of glial-derived neurotrophic factor (Gdnf) from the mesenchyme and binding to 
its respective receptor, Ret (Proto-oncogene tyrosine-protein kinase receptor), in the 
primary nephric duct71. The lack of Gdnf-Ret signaling in mutant mice leads to renal 
agenesis. Nevertheless, other yet unknown pathways independent of Gdnf-Ret signaling 
are assumed to play a role in ureteric bud initiation68. One might involve Wt1. In 
conventional Wt1 knock-out mice ureteric bud outgrowth fails to occur and the 
metanephric blastema undergoes apoptosis59, which also results in renal agenesis. 
However, Gdnf signaling is unaffected72.  
Wt1 seems to play a role in nephron induction as well. Nephron development or 
differentiation depends on initial signals released from the ureteric duct. This process is 
mainly regulated by the canonical Wnt-ß-catenin pathway, with Wnt9b (wingless-type 
MMTV integration site 9b) being the key player73, 74. Wnt9b is expressed in and released 
from the ureteric duct stalk, but is absent from the ureteric tips. In Wnt9b knock-out mice 
first-stage nephrogenic markers Lim homeobox protein 1 (Lim1), paired-box 8 (Pax8), 
Fibroblast growth factor 8 (Fgf8) and Wnt4 are not detectable in the mesenchyme75. Wnt4 
has proven to be both necessary and sufficient for induction of nephron formation. The 
latter process does not take place in respective knock-out mice76. Together with Fgf8 (REFS 
77, 78) and Pax2 (REF. 79), Wt1 (REF. 80) is part of a complex network to induce Wnt4 
expression and is therefore equally important for nephron induction. Recent findings from 
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kidney culture experiments suggest that reduction of Wt1 expression levels not only 
prevents nephron initiation to take place, but also leads to abnormal proliferation of 
mesenchymal cells81. It is conceivable that loss of Wt1 function at this stage arrests 
nephron precursor cells in a multipotent state. Subsequent transformation of these cells 
might contribute to Wilms Tumor formation. 
Segmentation and maturation is the last step in nephron development. In this process the 
different compartments, proximal and distal tubules, Henle loop and glomerulus, 
differentiate along the proximal-distal axis. For glomerular differentiation and maturation 
podocytes and their respective precursor cells are of vital importance. Podocyte precursor 
cells secrete vascular endothelial growth factor (Vegf) that attracts endothelial cells82, 
which themselves release platelet derived growth factor (Pdgf) necessary for the 
differentiation of mesangial cells83. Wt1 is highly expressed in podocyte precursors and is 
involved in the regulation of Vegf expression26, 82, 84. Furthermore, it acts as repressor for 
Pax223. This seems to be of particular importance for podocyte differentiation itself, since 
ectopic Pax2 expression in mice causes severe glomerular disease85, 86. In the adult kidney 
Wt1 expression remains restricted to podocytes. 
1.4 Podocytes and Wt1 
The podocyte (Fig. 3 A) fulfills important tasks in the developing glomerulus and is vital for 
function and maintenance of the renal filtration barrier (Fig. 3 B) in the adult organism. It’s 
most prominent feature is the ability to form extending primary and secondary processes 
(foot processes) and the associated slit diaphragm. The latter resembles adherens-like 
intracellular junctions. Important factors constituting this unique structure include the 
transmembrane proteins nephrin (Nphs1)87, 88, Neph189, P-cadherin90 and Fat, a member of 
the cadherin superfamily91. Expression of the respective genes is restricted to late-stage 
and mature podocytes. Nephrin is the best studied component of the slit diaphragm; 
NPHS1 has been identified as the gene mutated in congenital nephrotic syndrome of the 
Finish type, an autosomal-recessive disease with an incidence of 1 in 10,000 neonates in 
Finland87. It is characterized by defects of the renal filtration barrier resulting in massive 
proteinuria and, ultimately, in end stage renal failure, when untreated. Nphs1 knock-out 
animals die 24 hours after birth and display massive proteinuria paralleled by effacement 
(loss) of foot processes and absence of the slit diaphragm92. In vitro experiments suggest 
that Wt1 is involved in Nphs1 regulation22.  
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The slit diaphragm is covered by a thick coat rich of sialoglycoproteins such as podocalyxin 
(Podxl), which contributes to the highly negative surface charge of podocytes93. Podxl 
knock-out mice die shortly after birth from anuric renal failure. Podocytes develop, but fail 
to form foot processes and slit diaphragms94. Studies on rat embryonic kidney cell 
precursors gained some evidence for direct activation of Podxl by Wt121.  
A number of factors located at the cytoplasmatic side of the foot process membrane link 
the slit diaphragm and its constituents to the cytoskeleton. To this group of linkers belong 
podocin (Nphs2), CD2-associated protein (Cd2ap) and zona occludens protein 1 (Zo-1), 
among others. NPHS2 is mutated in patients with autosomal-recessive steroid-resistant 
nephrotic syndrome, which is a rapidly progressing disease resulting in end-stage renal 
failure. A comparable phenotype was diagnosed in mice carrying an Nphs2 mutation 
frequently found in nephrotic patients. Apart from strong proteinuria and 
glomerulosclerosis, podocyte anomalies including widespread foot process effacement 
were observed95. Nphs2 deficient mice harbor similar phenotypical features, such as 
proteinuria and glomerulosclerosis. They die shortly after birth from renal failure96. Cd2ap 
knock-out mice have a comparable, but less severe phenotype97. Podocin is thought to 
form a hairpin-like structure associated with the foot process membrane directly at the 
insertion site of the slit diaphragm. It has also been shown to interact with Cd2ap and 
nephrin98, 99.  
Another important podocyte/glomerular marker is synaptopodin; the function of the latter 
is not yet clearly defined, but it is associated with actin molecules of the cytoskeleton and 
regulates the actin-bundling activity of alpha-actinin, another cytoskeleton-associated 
protein100, 101. Synaptopodin is distributed along the entire podocyte with highest 
concentration in foot processes.  
Insights into Wt1 function at late stages of nephron development and podocyte 
differentiation have mostly been gained by studies of organ culture and cell culture 
systems. This includes findings about transcriptional targets Wnt4, Pax2, Vegf, nephrin and 
podocalyxin. Since kidney development does not proceed beyond initial stages in 
conventional Wt1 knock-out mice, in vivo data are rare. However, some mouse models 
predominantly harboring mutant forms of Wt1 are available and have served to underline 
the general importance of this gene for proper podocyte function and maintenance. One 
approach aimed to rescue the Wt1 knock-out phenotype by introduction of a yeast 
artificial chromosome expressing human WT1 into the genome of Wt1-null animals. WT1 
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expression could be restored to up to 70% of wild-type levels. However, mice developed 
severe glomerular defects and died rapidly from end stage renal failure102.  
Mice carrying different Wt1 mutations observed in patients with Denys-Drash syndrome 
(DDS) have been generated: a mutation that truncates zinc finger 3 at codon 396 also 
induced the typical urogenital anomalies of DDS in mice. Expression of podocyte-specific 
genes was significantly lower in mutant animals and Pax-2 was found to be misexpressed 
in some cases. But it was not clear, whether this was the cause or a result of disease 
progression and podocyte damage103-105. Introduction of the most frequently observed 
DDS mutation led to the development of some DDS symptoms in mice. Molecular changes 
including up-regulation of Cd2ap and Podocin, however, could not be directly linked to the 
reduction of Wt1 protein levels106. Thus, the molecular role of Wt1 in podocytes and 
associated diseases remains to be defined. 
1.5 Aim of this work 
The overall intention of this work was to gain in vivo information on Wt1-function in (1) late 
stages of kidney and podocyte development and (2) podocyte maintenance in the adult 
animal. For the first, developmental approach a mouse line was generated allowing 
podocyte-restricted Wt1-deletion from a late developmental stage on. In a second 
approach, an inducible podocyte-specific Wt1-knock-out mouse line was used to analyze 
Wt1 function in podocytes of adult animals.  
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2 Materials and Methods 
2.1 Materials 
2.1.1 Oligonucleotides 
Oligonucleotides for PCR applications were designed using the freely accessible online 
programs Primer3 (http://frodo.wi.mit.edu/primer3/) and Metabion Oligonucleotide 
Properties Calculator (http://www.metabion.com/support/biocalc.php). All 
oligonucleotides utilized in this study were obtained from Metabion (Germany) or 
Eurofins/MWG (Germany) and are listed in table 2. 
Table 2 Oligonucleotides 
Type Name Sequence Reference 
LoxP 
amplification 
Wt1flox-5’loxP-1F ACTGCTGACGAGAGTTAGGACA This work 
Wt1flox-5’loxP-1R AGATGGAGGCATCCAGTAAAGA This work 
Southern 
Blot probe 
ENG1-W1 AAGAGCAGACTGCACTCGCAGCTGG This work 
ENG1-W2 GAGACCTTCTTGTGGCTGCTCAGCC This work 
Genotyping Cre-RS-1F TCGACCAGGTTCGTTCACTC This work 
Cre-RS-1R CATCCTTAGCGCCGTAAATC This work 
rtTA-podoprobe-F CGCACTTCAGTTACTTCAGGTCCTC Shigehara et al.107 
rtTA-podoprobe-B GCTTATGCCTGATGTTGATGATGC Shigehara et al.107 
Wt1-CreX-1F GACCGTTGAACTGGCTCAG This work 
Wt1-CreX-1R GTCCGGGCAAGTTAAAGGG This work 
Wt1flox-1F GCCCTACAGCAGGTAAGAAGG This work 
Wt1flox-1R CTGGAGACCTGAGACAAGCA  This work 
qRT-PCR Nephrin-1F GTTCAGCTGGGAGAGACTGG This work 
Nephrin-1R GTCCACGATGCACTGGTAAG This work 
Podocin-1F GAGAGCGAGCGACCAGAG This work 
Podocin-1R TGCAGAACCAGATGGAAAAAG This work 
Cd2ap-1F TAAATGGGAGACGAGGGATG This work 
Cd2ap-1R GCTTTGGTTTGTGGATGTGG This work 
Synpo-1F GAGGCACGAGGTGGTTTC This work 
Synpo-1R GCCTCCTTCAGGTCGTTTTC This work 
Tbp-1F GGCCTCTCAGAAGCATCACTA Klattig108 
Tbp-1R GCCAAGCCCTGAGCATAA Klattig108 
Wt1-1F AGTTCCCCAACCATTCCTTC Klattig et al.108, 109  
Wt1-5R TTCAAGCTGGGAGGTCATTT Klattig et al.108, 109 
2.1.2 Plasmids  
The TA-cloning vectors pCRII-TOPO and pCR4-TOPO (both Invitrogen, USA) were used for 
cloning, sequencing and DNA-probe propagation. 
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2.1.3 Bacterial strains 
Escherichia coli strains used for cloning, sub-cloning and plasmid propagation: 
DH5α Recombination defective, suppressive strain; genotype: fhuA2 Δ(argF-
lacZ)U169 phoA glnV44 Φ80 Δ(lacZ)M15 gyrA96 recA1 relA1 endA1 thi-1 
hsdR17 
TOP10F’ Chemically competent strain for high efficiency transformation; 
genotype: F´ (lacIq Tn10 (TetR)) mcrA Δ(mrr-hsdRMS-mcrBC) 
Φ80lacZΔM15 ΔlacX74 recA1 araD139 Δ(ara-leu)7697 galU galK rpsL 
endA1 nupG (Invitrogen, USA) 
2.1.4 Antibodies 
Anti-Wt1 (human, mouse, rat), (C-19), rabbit polyclonal (Santa Cruz Biotechnology, USA) 
Anti-Synaptopodin (human, mouse, rat), (G1D4), mouse monoclonal (Progen Biotechnik, 
Germany) 
Anti-Podocin (mouse), (G-20), goat polyclonal (Santa Cruz Biotechnology, USA) 
Anti-rabbit IgG, goat, Alexa Fluor 546 labeled (Invitrogen, USA) 
Anti-mouse IgG, goat, Alexa Fluor 488 labeled (Invitrogen, USA) 
Anti-goat IgG, rabbit, Alexa Fluor 488 labeled (Invitrogen, USA) 
2.1.5 Mice 
The original transgenic mouse lines used in this work are listed in table 3. Mice were in 
C57BL/6J genetic background. Only animals from the Wt1flox strain or animals derived 
from crossings with Wt1flox mice were of mixed C57BL/6J/129/SvPas origin. 
Table 3 Transgenic mouse lines 
Line Description Provider Reference 
Wt1flox Mouse line carrying two loxP sites flanking exons 2 and 3 of the Wt1 gene  This work 
Podocin-Cre 
Mouse line harboring a Cre transgene; the 
expression of which is controlled by a NPHS2 
promoter fragment 
Ralph Witzgall, 
University of 
Regensburg 
Moeller et 
al.110, 111 
Podocin-rtTA 
Mouse line, in which rtTA (reverse 
tetracycline inducible transactivator) 
expression is governed by a NPHS2 promoter 
fragment 
Ralph Witzgall, 
University of 
Regensburg 
Shigehara et 
al.107 
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LC-1 
Mouse line transgenic for Cre recombinase 
and luciferase. Expression of both is 
controlled by a bidirectional rtTA-responsive 
promoter element 
Ralph Witzgall, 
University of 
Regensburg 
Schonig et 
al.112 
Rosa26-LacZ 
Cre reporter mouse strain carrying a 
transgene that consists of a CMV promoter 
fragment, a stop cassette flanked by loxP 
sites and the E. coli lacZ gene 
Carmen Birch-
meier-Kohler, 
Max-Delbrück-
Centrum Berlin 
Soriano113 
All animal experiments were performed in the Animal Facility of the Leibniz Institute for 
Age Research – Fritz Lipmann Institute (FLI), Jena, Germany, according to the rules of the 
German Animal Welfare Law and were licensed by the local authorities. This is consistent 
with the International Guiding Principles for Biomedical Research Involving Animals 
developed by the Council for International Organizations of Medical Sciences (CIOMS). The 
animals were housed under specific pathogen-free or pathogen-reduced conditions in a 
12 h light cycle and were provided with standard mouse chow and tap water ad libitum. 
2.2 Methods 
2.2.1 Standard techniques 
Standard molecular biology techniques, such as plasmid propagation and isolation, 
preparation of DNA and RNA, enzymatic manipulation of DNA and RNA and polymerase 
chain reaction (PCR) were performed according to Sambrook et al.114 and/or Ausubel et 
al.115. 
2.2.2 Generation of a conditional Wt1 knock-out mouse line  
Wt1 conditional knock-out mice (Wt1flox mice) were generated by introduction of loxP 
sites upstream of exon 2 and downstream of exon 3 of the Wt1 gene. The corresponding 
targeting construct was generated by genOway (Lyon, France) and is based on a PAC clone 
containing the murine Wt1 genomic sequence116. Electroporation of 129/SvPas ES cells, 
microinjection into C57BL/6J blastocysts, production of germline transmitting chimeras 
and, eventually, Wt1fl/+ animals were also performed by genOway. PCR and Southern Blot 
based screenings for correct targeting of and homologous recombination in ES cells and 
chimeric animals were accomplished as part of the PhD work. To confirm correct transgene 
integration in resulting Wt1flox mice, Southern Blot analysis (2.2.5) was performed. 
Furthermore, loxP sites were amplified and sequenced. The primers Wt1flox-5’loxP-1F and 
Wt1flox-5’loxP-1R were used to amplify the 5’ loxP site, and the primers Wt1flox-1F and 
Wt1flox-1R served to amplify the 3’ loxP site. Both PCR products were subsequently cloned 
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into the TA cloning vector pCR4-TOPO (Invitrogen, USA) and sent to Eurofins/MWG for 
sequencing. 
2.2.3 Generation of podocyte-specific Wt1 knock-out mice 
2.2.3.1 Constitutive podocyte-specific Wt1 knock-out mouse line (Wt1flox;Podocin-Cre) 
For the generation of a constitutive podocyte-specific Wt1 knock-out mouse line animals 
of the Wt1flox and Podocin-Cre strains were crossed according to the following procedure: 
Wt1fl/fl mice were mated with individuals hemizygous for the Podocin-Cre transgene to 
obtain Wt1fl/+;Pod-Cre mice in the F1 generation. These double heterozygous F1 animals 
were again crossed with Wt1fl/fl mice to produce homozygously floxed and Podocin-Cre 
hemizygous animals (Wt1fl/fl;Pod-Cre) in the F2 generation. Wt1fl/fl and Wt1fl/+;Pod-Cre mice 
derived from this crossing (litter mates) were used as controls. 
2.2.3.2 Inducible podocyte-specific Wt1 knock-out mouse line (iWt1-KO) 
Wt1fl/fl mice were mated with LC-1/+ and Podocin-rtTA/+ animals, respectively, to obtain 
Wt1fl/+;LC-1, as well as Wt1fl/+;Podocin-rtTA mice in the F1 generation. Double-heterozygous 
individuals from both newly generated lines, Wt1flox;LC-1 and Wt1flox;Podocin-rtTA, were 
again crossed with Wt1fl/fl animals to produce in the F2 generation Wt1fl/fl;LC-1 and 
Wt1fl/fl;Podocin-rtTA mice, respectively. Intercrossing of Wt1fl/fl;LC1 with Wt1fl/+;Podocin-rtTA 
individuals yielded both, Wt1fl/fl;Podocin-rtTA;LC-1 mice (iWt1-KO) and Wt1flox/+;Podocin-
rtTA;LC-1 control animals with a frequency of 12.5% each in the F3 generation. To induce 
Cre expression a solution of 5% sucrose and 2 mg/ml doxycycline hyclate (AppliChem, 
Germany) in tap water was administered. 
2.2.4 Genotype determination of transgenic mice by PCR 
For routine genotyping tail tips of 10 day old mice were clipped and DNA was isolated by 
tissue lysis with 10 mg/ml proteinase K (Roche, Switzerland) in PBND buffer at 55°C for 12 
h. Proteinase K was inactivated by boiling at 95°C for 15 min. Then 1 µl sample was used for 
subsequent PCR based genotype analysis. To verify the presence of floxed Wt1 alleles 
(Wt1flox PCR), primers Wt1flox-1F and Wt1flox-1R were applied. The Podocin-Cre, LC-1 and 
Rosa26-LacZ transgenes were detected using Cre-specific primers Cre-RS-1F and Cre-RS-1R 
(Cre PCR). Primers rtTA-podoprobe-F and rtTA-podoprobe-B were utilized to determine 
whether or not the Podocin-rtTA transgene was present in the genome of analyzed mice. 
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For all PCR reactions the Qiagen Taq polymerase/Buffer system (Qiagen, Germany) was 
applied. Master mix compositions and PCR conditions are indicated below. 
Cycler program Wt1 flox PCR  
Cycles Temp [°C] Duration [s] Gradient 
1 94 120  
 94 20  
10 65 20  -0.7°C/cycle 
 72 35  
 94 20  
30 58 20  
 72 35  
1 4 ∞  
 
Cycler program Cre PCR  
Cycles Temp [°C] Duration [s] Gradient 
1 94 120  
 94 20  
10 65 20  -0.7°C/cycle 
 72 30  
 94 20  
30 58 20  
 72 30  
1 4 ∞  
 
Cycler program Podocin-rtTA PCR 
Cycles Temp [°C] Duration [s] Gradient 
1 95 120  
 95 20  
40 58 20  
 72 35  
1 4 ∞  
 
 
To prove Cre activity and Wt1 deletion, respectively, DNA was obtained from total 
embryonic and newborn kidneys as well as adult kidney samples. For this the QIAamp DNA 
Mini and Micro kit (Qiagen, Germany) were used, following the provided protocols for DNA 
isolation from tissues. DNA was eluted and stored in 10 mM Tris-HCl, pH 8.0. The PCR was 
then performed with 100 ng total kidney DNA as template, Dream Taq polymerase/Buffer 
system (Fermentas, Lithuania) and primers Wt1-CreX-1F and Wt1-CreX-1R. For master mix 
compositions and PCR conditions see tables below. 
Master mix Wt1flox PCR  
Ingredient Final conc Volume [µl] 
DNA  1 
Primer 1 0.25 µM 0.5 
Primer 2 0.25 µM 0.5 
10x PCR buffer 1x 2 
dNTP mix 200 µM 0.4 
Polymerase 0.0125 U/µl 0.05 
H2O  15.55 
Volumetotal  20 
Master mix Cre PCR  
Ingredient Final conc Volume [µl] 
DNA  1 
Primer 1 0.4 µM 0.8 
Primer 2 0.4 µM 0.8 
10x PCR buffer 1x 2 
dNTP mix 200 µM 0.4 
Polymerase 0.0125 U/µl 0.05 
H2O  14.95 
Volumetotal  20 
Master mix Podocin-rtTA PCR 
Ingredient Final conc Volume [µl] 
DNA  1 
Primer 1 0.25 µM 0.5 
Primer 2 0.25 µM 0.5 
10x PCR buffer 1x 2 
dNTP mix 250 µM 0.5 
Polymerase 0.025 U/µl 0.1 
H2O  15.4 
Volumetotal  20 
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Cycler program Wt1 deletion PCR 
Cycles Temp [°C] Duration [s] Gradient 
1 94 60  
 94 20  
10 65 20  -0.7°C/cycle 
 72 60  
 94 20  
26 58 20  
 72 60  
1 72 5  
1 4 ∞  
 
2.2.5 Southern Blot analysis 
2.2.5.1 Generation of radioactively labeled DNA probes 
DNA probes for Southern Blot analyses were synthesized and radioactively labeled using 
the NEBlot Kit (New England Biolabs, USA). Briefly, probe synthesis was performed in vitro 
from a denatured double-stranded DNA template by the Klenow fragment of the 
Escherichia coli DNA polymerase I. Replacement of dCTP with [alpha-32P]dCTP in the 
reaction mix allowed simultaneous radioactive labeling of the probe. Readily labeled 
probes were afterwards purified with ProbeQuant G-50 Micro Columns (GE Healthcare, 
USA).  
The DNA template to generate the 406 bp Wt1 specific probe applied in this study was PCR 
amplified utilizing primers ENG1-W1 and ENG1-W2 (See table 2 for primer sequences) and 
cloned into pCRII-TOPO with the TOPO TA Cloning Kit (Invitrogen, USA). Prior to probe 
synthesis and labeling the DNA fragment was released from the vector by EcoRI 
(Fermentas, Lithuania) restriction enzyme digestion and purified employing agarose gel 
extraction kits QiaExII (Qiagen, Germany) or PeqGold (Peqlab, Germany). 
2.2.5.2 Southern Blot analysis of mouse genomic tail DNA 
Mice were anesthetized by inhalation of isoflurane (Deltaselect, Germany), before 
approximately 1 cm of the tail tip was clipped. Genomic DNA was isolated using the 
QIAamp DNA Mini Kit (Qiagen, Germany), according to the provided protocol for DNA 
purification from tissues. DNA was eluted with and stored in 10 mM Tris-HCl, pH 8.0. 5 to 10 
µg of purified total genomic DNA were digested with 80 units of BamHI (Fermentas, 
Lithuania) for 12 to 16 h at 37°C. Following digestion, DNA was precipitated with 100% 
ethanol for 12 h at 4°C, washed with 70% ethanol and redissolved in 10 mM Tris-HCl, pH 
8.0, for 12 to 24 h at 4°C. After addition of an appropriate volume of 10x DNA Loading Dye 
Master mix Wt1 deletion PCR 
Ingredient Final conc Volume [µl] 
DNA  2 
Primer 1 0.25 µM 1.25 
Primer 2 0.25 µM 1.25 
10x PCR buffer 1x 5 
dNTP mix 200 µM 1 
Tween 20 0.5% 0.25 
Polymerase  0.2 
H2O  39.05 
Volumetotal  50 
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the DNA was loaded onto a 1.0% TBE agarose gel supplemented with 1 µl/100 ml ethidium 
bromide (Stock 5 mg/ml; Roth, Germany). Hyperladder I (Bioline, Germany) served as 
marker. After electrophoresis in 1x TBE Buffer at 100 V the gel was treated with (1) 0.125 M 
HCl for 10 min to depurinate DNA and (2) 0.4 M NaOH for 30 min to denature DNA. After 
that DNA was transferred to a positively charged nylon membrane (Hybond-XL; GE 
Healthcare, USA) by alkaline transfer with 0.4 M NaOH using a self-made capillary blotting 
chamber. Following a transfer process of 12 to 16 h, DNA and nylon membrane were cross-
linked by exposure to 0.12 J/cm2 of UV light (λ=312 nm). Prior to hybridization the blotting 
membrane was pre-incubated with modified Church-Gilbert Hybridization Buffer for at 
least 30 min at 65°C. Then the hybridization buffer was replaced by a fresh volume of pre-
heated buffer and the previously denatured radioactive probe (95°C, 5 min) was added 
according to a final activity of 2,000,000 cpm/ml. After hybridization for 16 h at 65°C in a 
rotation oven the membrane was washed at 65°C in pre-warmed Low-Stringency Washing 
Solution for 15 min and in High-Stringency Washing Solution for another 15 min. 
Radioactivity was detected and visualized with a phosphoimager system (FLA-7000, 
Fujifilm, Japan). 
10x DNA Loading Dye 0.25% bromophenol blue; 0.25% xylene cyanol; 67% (w/v) sucrose; 
in dH2O 
1x TBE Buffer 90 mM Tris-HCl; 90 mM boric acid; 2.5 mM EDTA; pH 8.3 
Modified Church-Gilbert Hyb. Buffer 1 mM EDTA; 500 mM Na2HPO4, pH 7.2; 7% SDS 
Low Stringency Washing Solution 3x SSC, pH 7.0; 0.1% SDS 
High Stringency Washing Solution 0.5x SSC, pH 7.0; 0.1% SDS 
2.2.6 Isolation, treatment and embedding of kidneys for paraffin and frozen sections 
Newborn (P0) mice were sacrificed by decapitation. Kidneys were instantly isolated and 
either dehydrated in 10% and 30% sucrose for 10 min and 30 min, respectively, or fixed in a 
solution of 1x phosphate buffered saline (PBS, pH 7,2) and 4% paraformaldehyde (PFA; 
Merck, Germany) for 12 – 14 hours at 4 – 8°C. Adult mice were anaesthetized by combined 
intraperitoneal injection of ketamine (80 mg/kg bodyweight; Ketavet, Pfizer, USA) and 
xylazine (8 mg/kg bodyweight; Rompun, Bayer, Germany). Then animals were perfused 
with 40 ml ice-cold 1x PBS through the left ventricle of the heart. Kidneys were obtained, 
cut into two halves and kidney poles were removed. Kidney halves were subsequently 
dehydrated in 10% sucrose for 10 min and 30% sucrose for 30 min - 2 h, or else fixed for 24 
h in 4% PFA/1x PBS at 4 – 8°C. For preparation of frozen sections dehydrated P0 kidneys 
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and adult kidney halves were embedded in Neg -50 Frozen Section Medium (Thermo-
Fisher-Scientific, USA) and frozen at -80°C. Sections (10 µm) were prepared on a Microm 
HM 550 cryotome (Microm, Germany) and mounted on SuperFrost slides (Menzel, 
Germany). To obtain paraffin sections PFA-fixed P0 kidneys and adult kidney halves were 
dehydrated in graded series of isopropanol or ethanol, infiltrated with chloroform or 
xylene and embedded in Paraplast or Paraplast X-Tra (McCormick Scientific, USA) 
according to standard procedures. Paraffin sections (5 µm) were prepared on a Microm HM 
340 E microtome (Microm, Germany) and mounted on poly-lysine coated slides (Menzel, 
Germany). 
1x PBS 137 mM NaCl; 2.7 mM KCl; 4.3 mM Na2HPO4; 1.47 mM KH2PO4; pH 
7.2 
4% PFA/1x PBS 4% (w/v) paraformaldehyde in 1x PBS 
2.2.7 Periodic acid-Schiff staining (PAS) 
Paraffin sections were dewaxed in xylene, rehydrated in a graded ethanol series and 
washed with dH2O. Then sections were incubated in 0.5% Periodic acid (Roth, Germany) for 
5 min at room temperature and washed 1 min with frequently exchanged dH2O. After 
washing, sections were incubated in Schiff-Reagent (Roth, Germany) for 15 min at room 
temperature and rinsed with running tap water for at least 3 min. For counter staining 
Mayer’s Hematoxylin (Roth, Germany) was applied for 1 min. Sections were subsequently 
rinsed with running tap water for at least 3 min or submerged in 1x PBS for 1 min, washed 
with dH2O, dehydrated in 95% ethanol, 100% ethanol and two changes of xylene and 
finally mounted using Cytoseal XYL (Thermo Fisher Scientific, USA) or Roti-Histokitt II (Roth, 
Germany). Sections were analyzed using a Zeiss Axiovert 135 TV inverse microscope. 
Pictures were taken with a Zeiss AxioCam MRc digital color camera. 
2.2.8 Immunohistochemistry 
Cryo sections were fixed in cold (4°C) 4% PFA/1x PBS or 100% acetone for 10 min, washed 
three times in 1x PBS/0.01% Triton-X and blocked for 30 min in Blocking Solution. After 
washing with 1x PBS/0.01% Triton-X, sections were incubated with primary antibodies 
solved in 1x PBS for 12 – 14 h at 37°C. Primary antibodies were applied in the following 
dilutions: Wt1 antibody 1:100; Podocin antibody 1:100; Synaptopodin antibody 1:200. 
Sections were then washed three times with 1x PBS/0.01% Triton-X and incubated with 
1:500 dilutions of secondary antibodies in 1x PBS for 1 h at room temperature. Before 
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mounting with Prolong Gold (Invitrogen, USA), sections were treated with a 1:100 dilution 
of Hoechst 33342 Staining (Invitrogen, USA) in 1x PBS for 10 min and briefly washed with 
1x PBS. Alternatively, sections were mounted using Vectashield/DAPI (Vector Laboratories, 
USA). Sections were analyzed with a Zeiss Axioimager.Z1 microscope. Pictures were taken 
with a Zeiss AxioCam MRm digital camera. 
Blocking Solution 1% (w/v) bovine serum albumin (BSA); 0.6% (w/v) normal goat 
serum (NGS); 1% (v/v) DMSO; 0.5% (v/v) Tween-20; in 1x PBS 
2.2.9 Apoptosis assay (TUNEL) 
Apoptosis in newborn kidneys was analyzed using the ApopTag Plus In Situ Apoptosis 
Detection Kit (Chemicon, USA) according to the instructions of the manufacturer. Briefly, 5-
µm paraffin kidney sections were dewaxed in xylene, rehydrated in a graded ethanol 
series, washed with 1x PBS, fixed in 4% PFA/1x PBS for 15 min, again washed in 1x PBS, 
permeabilized for 15 min with 10 µg/ml proteinase K (Roche, Switzerland), washed and 
refixed in 4% PFA/1x PBS for 5 min. After additional washing with 1x PBS, endogenous 
peroxidase activity was quenched by treatment of sections with 3% H2O2/1x PBS for 5 min. 
Sections were again washed with 1x PBS, excess liquid was carefully removed and 100 
µl/slide Equilibration Buffer was applied for 10 min. After removal of excess liquid, 100 
µl/slide TdT (Terminal Deoxynucleotidyl Transferase) reaction mixture, consisting of TdT 
Reaction Buffer and TdT enzyme, was added to sections. Slides were then covered with 
plastic-cover slips and incubated for 1 h at 37°C in a humidified chamber. The TdT reaction 
was stopped through treatment of sections with Stop/Wash Buffer (1:35 dilution of 
Stop/Wash Buffer in dH2O) for 10 min and washing in three changes of 1x PBS. Excess 
liquid was removed, 100 µl/slide Anti-Digoxigenin-Peroxidase Antibody Solution was 
added, slides were again covered with plastic cover slips and incubated for 30 min at room 
temperature in a humidified chamber. Following washing with four changes of 1x PBS, 80 
µl/slide Peroxidase Substrate, being a 1:50 dilution of DAB (3,3’-diaminobenzidine) 
substrate in DAB Dilution Buffer, was applied for 3 to 8 min until a light brown background 
staining was noticeable on sections. Then sections were immediately washed with four 
changes of dH2O, counterstained with 0.5% Methyl-Green (Labvision, USA) for 3 min, 
dehydrated in 95% ethanol, 100% ethanol and xylene and mounted using Cytoseal XYL 
(Thermo Fisher Scientific, USA). Sections were examined on a Zeiss Axiovert 135 TV inverse 
microscope. Pictures were taken using a Zeiss AxioCam MRc digital color camera. 
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Proteinase K Buffer 20 mM Tris-HCl, pH 7.5; 1 mM EDTA 
2.2.10 Transmission electron microscopy (TEM) 
Newborn (P0) mice were sacrificed by decaptitation, kidneys were harvested, washed in 1x 
PBS, fixed in a freshly prepared solution of 2% glutaraldehyde (Sigma, USA) in1x PBS for 2 d 
at 4°C and conserved for 2 – 4 d in 1x PBS-buffered 0,02% sodium azide (Merck, Germany) 
at 4°C. Kidneys were sent in 1x PBS to Prof. Dr. Ralph Witzgall, University of Regensburg. 
Adult mice were deeply anaesthetized with xylazine/ketamine (described in 2.2.4) and 
perfused with 40 ml freshly prepared 2% glutaraldehyde/1x PBS through the heart’s left 
ventricle. After isolation, kidneys were cut into small pieces of approximately 1 mm3 and 
post-fixed in 2% glutaraldehyde/1x PBS for 3 – 4 d at 4°C. Following this procedure, 
newborn and adult kidney pieces were extensively washed with 1x PBS, infiltrated with 2% 
osmium tetroxide (OsO4)/1x PBS for contrasting, washed with 1x PBS, dehydrated in a 
graded ethanol series and embedded in EPON 812 (Shell, UK). Ultrathin sections were 
prepared on a Leica EM UC6 microtome and mounted on copper slot grids coated with 
polyvinyl butyral film (Pioloform; Wacker, Germany). Sections were analyzed using a Zeiss 
CEM 902 TEM. All TEM analyses were performed in the group of Prof. Dr. Ralph Witzgall, 
University of Regensburg. 
2.2.10.1 Polyehtylenimine (PEI) staining 
Kidneys of sacrificed adult mice were isolated, cut into 1 mm3 pieces, stained with 0.5% 
polyethyleneimine (PEI) in 0.9% NaCl, pH 7.3, for 30 min, washed with three changes of 50 
mM sodium cacodylate for 10 min each, fixed in 2% phosphotungstic acid/0.1% 
glutaraldehyde for 1 h, washed with 50 mM sodium cacodylate buffer, treated for 2h with 
1% OsO4 in 25 mM sodium cacodylate for contrasting, dehydrated and embedded in EPON 
812. 
2.2.11 Localization of Cre expression 
2.2.11.1 Generation of Rosa26-LacZ;Podocin-rtTA;LC-1 reporter mouse line 
In order to generate triple heterozygous mice, the following mating regime was applied: 
heterozygous animals of the Rosa26-lacZ and Podocin-rtTA strain were intercrossed 
resulting in double-heterozygous Rosa26-lacZ/+;Podocin-rtTA/+ mice (frequency 25%) in 
the F1 generation. Next, these double-heterozygous F1 animals were mated with LC-1 
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hemizygous individuals to obtain triple heterozygous mice in the F2 generation (frequency 
12.5%). 
2.2.11.2 Beta-galactosidase assay 
Cre expression was induced by administration of a 5% sucrose solution supplemented with 
2 mg/ml doxycycline (AppliChem, Germany) for 7 d. Mice were sacrificed, kidneys were 
immediately isolated, embedded in cryo matrix and sectioned, as described. 10 µm cryo 
sections were fixed in fixation solution for 10 min. After that, sections were washed three 
times with 1x PBS, stained in staining solution for 12 h at 37°C and washed again three 
times with 1x PBS. For counter staining sections were submerged in 0.5% eosin (Roth, 
Germany) for 1 min and washed once in dH2O. Following this, sections were dehydrated in 
a graded ethanol series and xylene, and were then mounted with Cytoseal XYL (Thermo 
Fisher Scientific, USA). Sections were analyzed on a Zeiss Axioimager.Z1 microscope. 
Pictures were taken with a Zeiss AxioCam MRc5 digital color camera. 
Fixation solution 1% formaldehyde; 0.2% glutaraldehyde; 2 mM MgCl2; 5 mM EGTA; 
0.02% NP-40 
Staining solution 0.1% (w/v) X-Gal (5-bromo-4-chloro-3-indolyl-β-D-galactoside); 5 
mM K3Fe(CN)6; 5 mM K4Fe(CN)6-3 H2O; 2 mM MgCl2; 0.01% sodium 
deoxycholate; 0.02% NP-40 
2.2.12 Proteinuria assay 
Urine was gathered from living animals or directly removed from bladders of sacrificed 
mice. 1 µl urine and 1 µl BSA solution (3 µg/µl; Sigma, USA), that served as control, were 
each complemented with 9 µl dH2O and 10 µl 2x Laemmli Sample Buffer, boiled for 5 min 
at 95°C and then loaded onto a 10% polyacrylamide gel, together with 5 µl Page Ruler 
Prestained Protein Ladder (Fermentas, Lithuania). Following electrophoresis in 1x Laemmli 
Running Buffer at 180 V, 30 mA the gel was stained in Coomassie Brilliant Blue R250 
according to standard procedures. 
2x Laemmli Sample Buffer 125 mM Tris-HCL, pH 6.8; 4% SDS; 20% glycerol; 0.004% 
bromophenol blue; 8% 2-mercaptoethanol 
1x Laemmli Running Buffer 25 mM Tris, pH 8.6; 192 mM glycin; 1% SDS 
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2.2.13 Real-time RT-PCR analyses (qRT-PCR) 
2.2.13.1 Glomerulus extraction, RNA isolation and DNaseI digestion 
Glomeruli were extracted from adult mouse kidneys following a method described by 
Takemoto et al.117 with modifications established by Blutke118. Briefly, adult mice were 
anesthetized with Ketamine/Xylazine as described in 2.2.6. Animals were perfused with 40 
ml of a solution containing magnetic beads with a diameter of 450 nm (Dynabeads M-450 
Epoxy, Invitrogen, USA) and 40°C 1x PBS through the heart. The perfusion pressure was 
kept constant at 60 mmHg. Kidneys were removed, minced into 1 mm3 pieces and treated 
with 1 mg/ml collagenase A (Roche, Switzerland) in 1x HBSS buffer for 30 min. Glomeruli 
were isolated using a BD IMag magnet (BD Biosciences, USA). After several rounds of 
washing/isolation glomeruli were lysed and homogenized in Trizol Reagent (Invitrogen, 
USA). RNA was isolated/purified from the aqueous phase employing the RNeasy Mini Kit 
(Qiagen, Germany). Prior to reverse transcription 770 ng RNA were treated with RQ1 
RNase-Free DNaseI (Promega, USA) for 30 min at 37°C. 
2.2.13.2 Reverse transcription 
For reverse transcription with SuperScript II RNase H- Reverse Transcriptase (Invitrogen, 
USA) and oligo-dT primers (Roche, Switzerland) 350 ng glomerular RNA were used. With 
the same amount of RNA a control reaction without reverse transcriptase (RT-) was set up 
in order to verify possible genomic DNA contamination. 10 µl of 1:10 dilutions of both, 
cDNA and control samples were used for subsequent real-time RT-PCR analyses. 
2.2.13.3 Quantitative real-time RT-PCR (qRT-PCR) 
Quantitative real-time RT-PCR analyses were performed in a 96-well format on a Biorad 
iCycler or iQ5 system. Gene expression levels of samples to be compared were measured in 
one plate simultaneously and were normalized to corresponding tbp (TATA-box binding 
protein) expression. Samples were measured in triplicates. Primers used for qRT-PCR were 
chosen to span at least one intron and are listed in table 2 (2.1.1). Master mix composition 
and basic PCR conditions are shown in tables below. 
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Cycler program qRT-PCR 
Cycles Temp [°C] Duration [s] 
1 94 60 
35 
94 30 
60 30 
72 30 
80 15 
1 8 ∞ 
 
 
 
SYBR Green I (Stock 10,000x; Sigma, USA) was used to detect DNA and was diluted 1:2,000 
prior to application. Fluorescein (FITC; Biorad, USA) served as calibration dye. Fluorescence 
was detected at an 80°C step following elongation at 72°C to decrease signals emitted 
from short primer-dimer sequences. After amplification, a melt curve was generated to 
verify the amount of primer-dimers formed in the PCR reaction. Differences in gene 
expression were calculated according to the double-delta-CT method119. 
10x PCR buffer 200 mM Tris-HCl, pH 8.4; 500 mM KCl 
1x HBSS 1.26 mM CaCl2-2H2O, 0.5 mM MgCl2-6 H2O, 0.4 mM MgSO4-7 H2O, 
5.33 mM KCl, 0.44 mM KH2PO4, 137.9 mM NaCl, 0.34 mM NaHPO4-2 
H2O, 5.55 mM alpha-D-glucose-1H2O 
 
Master mix qRT- PCR 
Ingredient Final conc Volume [µl] 
cDNA  10 
Primer 1 0.4 µM 1 
Primer 2 0.4 µM 1 
10x PCR buffer 1x 2.5 
dNTP mix 200 µM 0.5 
MgCl2 2 mM 0.75 
SYBR Green I  0.75 
FITC 400 pM 0.25 
Polymerase 0.03 U/µl 0.15 
H2O  8.1 
Volumetotal  25 
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3 Results 
In this study the function of Wt1 in developing and mature podocytes was addressed. To 
do so constitutive as well as inducible podocyte-specific Wt1 knock-out mice were 
generated using the loxP/Cre system120-123. The latter is based on the recognition and 
subsequent recombination of neighboring loxP sites, 34 bp inverted repeats, by the 
bacteriophage-P1-derived enzyme Cre-recombinase. Sequences or genomic regions 
located between two similarly orientated loxP sites are thus deleted. The basis for both 
podocyte-specific Wt1 knock-out mouse models was a conditional Wt1 knock-out mouse 
line (Wt1flox), in which parts of the gene are flanked by loxP sites. Animals expressing Cre in 
a podocyte-restricted manner were crossed into this background. 
3.1 The conditional Wt1 knock-out mouse 
3.1.1 The targeting strategy 
The strategy chosen to generate the conditional Wt1 knock-out mouse line comprised 
flanking of exons 2 and 3 of the genomic Wt1 locus with loxP sites (Fig. 5 A). Upon Cre-
mediated deletion joining of exons 1 (914 bp) and 4 (78 bp) during splicing of primary 
transcripts should result in a frame shift producing a pre-mature stop codon (Fig 5 B, C). 
The resulting mRNA molecules would probably be subject to nonsense mediated decay 
(NMD)124 or translated into truncated, non-functional Wt1 protein.  
 
Fig. 5. The conditional Wt1 knock-out mouse targeting strategy. (A) The targeting strategy is based on 
the insertion of loxP sites in the same orientation 5’ of exon 2 and 3’ of exon 3 of the Wt1 gene. (B) Wild-type 
Wt1 mRNA. (C) mRNA derived from the deleted Wt1 locus as a consequence of Cre activity. The terms Start 
and Stop symbolize corresponding codons; loxP, Cre recombinase recognition sites. 
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Fig. 6. Generation and genotyping of conditional Wt1 knock-out mice. (A) The Wt1flox targeting 
construct used to replace the Wt1 genomic sequence (wild type allele) by homologous recombination (B) 
Southern Blot strategy to genotype Wt1flox mice. BamHI sites are present in intron 1 and 3 of the wild type 
Wt1 allele yielding a 6 kb fragment upon enzymatic digestion. The floxed Wt1 allele contains an additional 
BamHI site integrated alongside with the 5’ loxP site. Restriction enzyme digestion results in a 4.1 kb 
fragment. (C) Southern Blot analysis of BamHI digested tail genomic DNA of Wt+/+ (+/+), Wt1fl/+ (fl/+) and 
Wt1fl/fl (fl/fl) mice showing presence and correct integration of the Wt1flox allele (4.1 kb fragment) only in 
the fl/+ and fl/fl mouse genome. B, BamHI restriction site; DTA, diphtheria toxin A cassette; FRT, Flp 
recombinase recognition site; loxP, Cre-recombinase recognition site; neo, neomycin resistance cassette. 
 
3.1.2 Generation of conditional Wt1 knock-out mice 
LoxP sites were integrated into the Wt1 locus of 129/SvPas embryonic stem cells (short ES 
cells) by homologous recombination with a targeting construct encompassing the 
following elements: the Wt1 homology region including exons 1 to 5, as well as respective 
5’ and 3’ flanking regions, loxP sites in introns 1 and 3, a neomycin-resistance cassette (neo) 
flanked by FRT sites for positive selection, and a diphtheria toxin A cassette (DTA) located 
outside the Wt1 homologous region for negative selection (Fig. 6 A). 
 
Seven correctly targeted ES cells were injected into wild type C57BL/6J blastocysts. Two of 
these seven ES cell clones produced offspring with a high rate of chimerism between 50 % 
and 98 %. Male chimeras were then bred with wild type C57BL/6J females. One male and 
two female F1 mice carrying the Wt1flox transgene were then crossed with C57BL/6J Flp 
deleter mice to remove the neomycin-resistance cassette by recombination of FRT sites. 
Finally, two mice of different sex and mixed C57BL/6J/129/SvPas genetic background were 
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obtained, both being heterozygous for the floxed Wt1 locus (Wt1fl/+). Intercrossing allowed 
the generation of homozygous animals.  
Correct targeting of Wt1flox mice was confirmed by Southern Blot based on a BamHI 
digestion strategy (Fig. 6 B and C). Additionally, 5’ and 3’ loxP sites were PCR-amplified, 
sub-cloned and sequenced. Both sites were present in the correct location within the 
intronic regions targeted and showed no sequence variation. 
3.2 Constitutive podocyte-specific knock-out of Wt1 
3.2.1 Generation of podocyte-specific Wt1 knock-out mice 
To generate a podocyte-specific Wt1 knock-out mouse line Wt1flox animals were crossed 
with mice from a Podocin-Cre line (Pod-Cre, in short) expressing Cre under the control of a 
2.5 kb promoter fragment of the human podocin gene (NPHS2)110. Transgene expression 
driven from this promoter is podocyte restricted and arises during late glomerular 
developmental stages (S-shaped body stage)111. Promoter activity is maintained in 
podocytes of mature glomeruli. 
3.2.2 Wt1 deletion is kidney specific and is first detectable at embryonic stage E14.5 
In order to determine, whether the conditional Wt1 knock-out is indeed kidney restricted, 
PCR on genomic DNA from different internal organs of newborn Wt1fl/fl;Pod-Cre mice and 
kidneys of control animals (Wt1fl/fl) was performed using primers flanking the floxed Wt1 
region. In case of Wt1 deletion a DNA fragment of 735 bp (Wt1Δ) should be amplified. The 
floxed allele on the other hand yields an amplification product of 1694 bp (Wt1flox). As 
shown in Fig. 7 A the Wt1Δ fragment was exclusively detectable in kidneys of the examined 
Wt1fl/fl;Pod-Cre mouse, not in other organs from the same animal, or in kidneys of a Wt1fl/fl 
litter mate control (termed ‘C’ in Fig. 7 A). This suggests that Wt1 deletion is a) strictly 
dependent on Cre expression and b) kidney/podocyte restricted.  
Wt1 deletion could first be detected in embryonic kidneys of E14.5 Wt1fl/fl;Pod-Cre mice (Fig. 
7 B) confirming that Cre expression arises at late S-shaped body stage, during nephron 
patterning and maturation. 
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Fig. 7. Detection of Cre-mediated Wt1-deletion by PCR (A) Genomic DNA of kidneys and indicated 
internal organs of newborn Wt1fl/fl;Pod-Cre mice was isolated and subjected to PCR using primers flanking 
the floxed Wt1 sequence. As control (indicated as ‘C’) kidney DNA of Wt1fl/fl animals was used. The 735 bp 
amplification product of the deleted Wt1 locus (Wt1Δ) is only yielded in PCR on Wt1fl/fl;Pod-Cre kidney DNA. 
Since Cre is exclusively expressed in podocytes, the undeleted Wtflox allele is present in all organs (1694 bp 
PCR product). (B) PCR to determine the time point of first Cre-mediated Wt1-deletion on kidney DNA from 
Wt1fl/fl;Pod-Cre mice of different embryonic stages (E13.5 to newborn, P0). Wt1-deletion (Wt1Δ fragment) is 
first detectable in kidneys of E14.5 mice. 
 
3.2.3 Wt1fl/fl;Pod-Cre animals die shortly after birth and exhibit severe damages of the 
renal filtration apparatus 
Wt1fl/fl;Pod-Cre mice were born at the expected Mendelian ratio. In contrast to double 
heterozygous litter mates, however, these animals died rapidly, 12 to 24 hours after birth. 
The bladders of newborn Wt1fl/fl;Pod-Cre animals were always found to be empty (anuria) 
and kidneys displayed red spots due to localized hemorrhages (Fig. 8 A). In Wt1fl/+;Pod-Cre 
and Wt1fl/fl litter mates this was never observed. Signs for ascites or edema as a possible 
consequence of kidney failure could not be detected. 
On the histological level the absence of urine could be explained by a strong reduction in 
the number of glomeruli (Fig. 8 C), as compared to Wt1fl/+;Pod-Cre controls (Fig. 8 B). The 
remaining glomeruli were markedly smaller in size and cell number (Fig. 8 E, arrow) in 
relation to those of control animals (Fig. 8 D, arrows). Additionally, degenerating glomeruli 
could be identified (Fig. 8 E, arrowhead), which were entirely absent from control kidney 
sections. Forms of glomerulosclerosis, often characterized by mesangial matrix expansion 
and frequently found in patients and mice with Wt1 mutations, were not observed in 
podocyte-specific Wt1 knock-out kidneys. Instead, proximal convoluted tubules, the 
tubular parts directly connected with glomeruli, were strongly reduced in number and 
appeared to be collapsed, most probably due to the absence of primary urine (Fig. 8 C). In 
kidneys of Wt1fl/+;Pod-Cre control animals proximal convoluted tubules appeared normal in 
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terms of number and shape (Fig. 8 B, dashed circle). In mice developing nephrons of 
different stages can be found in the outer cortex until approximately 7 days after birth. 
Microscopic analysis revealed no alteration in early nephrogenic stages in newborn 
Wt1fl/fl;Pod-Cre mice. 
 
3.2.4 Immunohistochemical analyses reveal significant loss of glomeruli  
To support the histological findings the presence of Wt1 and different glomerular marker 
proteins within the cortex of conditional knock-out kidneys was studied by double-
immunohistochemistry. As glomerular markers synaptopodin and podocin were used. 
Both factors are located in the cytoplasm of podocytes and are associated with the slit 
Fig. 8. Macroscopic and histological analysis of newborn Wt1fl/fl;Pod-Cre and control kidneys (A) 
Kidneys obtained from newborn Wt1fl/fl, Wt1fl/+;Pod-Cre and Wt1fl/fl;Pod-Cre litter mates. Superficial 
hemorrhages, indicated by red spots on the kidney surface, are present only in Wt1fl/fl;Pod-Cre kidneys. (B) 
Low and (D) high magnification of a PAS stained 5 µm paraffin section of a newborn Wtfl/+;Pod-Cre control 
kidney. Arrows indicate selected mature glomeruli, the dashed circle marks an exemplified zone of proximal 
convoluted tubules. (C) Low and (E) high magnification of a PAS stained 5 µm kidney paraffin section of a 
newborn Wt1fl/fl;Pod-Cre mouse. Here arrows indicate mal-developed glomeruli. The number of proximal 
convoluted tubuli in (C) is strongly reduced. Arrowhead (E) points to a degenerated glomerulus. 
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diaphragm. In concordance with published data, expression of Wt1 was strongest in 
developing nephrons of early developmental stages within the outer renal cortex (Fig. 9 A 
– D). These early nephrogenic structures do not yet exhibit synaptopodin or podocin 
synthesis. Extending into the inner cortex, Wt1 expression becomes gradually weaker and 
is less broad as in the outer cortex. Co-localization with synaptopodin or podocin indicated 
that it remained to be expressed solely in podocytes of pre-mature (Fig. 9 A and C, 
arrowheads) and more mature glomeruli (Fig. 9 A and C, arrows) of newborn Wt1fl/+;Pod-Cre 
kidneys. In conditional Wt1 knock-out animals, however, neither Wt1, nor synaptopodin or 
podocin are detectable within the inner renal cortex (Fig. 9 B and D). Considering 
histological results, this might be due to the absence of glomeruli. 
 
3.2.5 Loss of glomeruli is paralleled by enhanced apoptosis in the cortex of Wt1fl/fl;Pod-
Cre kidneys 
Using TUNEL technique it could be demonstrated that loss of glomerular and tubular 
structures in newborn Wt1fl/fl;Pod-Cre animals was paralleled by enhanced apoptosis along 
the renal cortex (Fig. 10 B). Higher magnification revealed that mostly detached podocytes 
of remaining glomeruli underwent programmed cell death (Fig. 10 D, arrows). Wt1fl/+;Pod-
Fig. 9. Presence of glomerular marker proteins and Wt1. Immunohistochemistry on 10 µm cryo sections 
using antibodies against Wt1 (red) and mature podocyte markers synaptopodin and podocin (green). (A 
and C) In the inner renal cortex (ic) of newborn Wt1fl/+;Pod-Cre kidneys Wt1, synaptopodin and podocin are 
detectable in pre-mature (arrowheads) and more mature glomeruli (arrows). However, none of the proteins 
are present in the inner renal cortex (ic) of Wt1fl/fl;Pod-Cre kidneys indicating absence of glomeruli. (A, B, C, 
D) In the outer renal cortex (oc) of all animals early nephrogenic structures are located showing high levels 
of Wt1. oc, outer renal cortex; ic, inner renal cortex. The dashed line roughly determines the border 
between outer and inner renal cortex. 
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Cre control animals exhibited only sporadic apoptotic cells within the outermost cortex, 
and none in glomeruli or tubules (Fig. 10 A and C).  
 
3.2.6 Ultrastructural studies reveal foot process effacement in podocytes of 
Wt1fl/fl;Pod-Cre animals 
Electron microscopic studies were performed to reveal possible structural changes in 
remaining glomeruli of newborn Wt1fl/fl;Pod-Cre kidneys. Wt1fl/+;Pod-Cre animals served as 
controls and exhibited normally developed glomeruli (Fig. 11 A). Podocytes of the latter 
were of normal appearance and had extensive foot processes (Fig. 11 C, arrows). In kidneys 
of podocyte-specific Wt1 knock-out mice, however, severe structural damages could be 
identified. A considerable number of glomeruli displayed single capillary vessels not 
covered by podocytes (Fig. 11 B, arrow). As a consequence, high amounts of proteinaceous 
material emanated from these vessels (Fig. 11 B, asterisk). Additional protein casts could be 
observed in pathologically dilated tubules. Furthermore, podocytes displaying widespread 
foot process effacement were identified in a major number of glomeruli (Fig. 11 C, 
arrowheads). Although glomerular basement membrane (GBM) and endothelial cell layer 
Fig. 10. Analysis of apoptosis in newborn Wt1fl/fl;Pod-Cre and control kidneys. TUNEL assay on 5 µm 
kidney paraffin sections counterstained with methyl green nuclear staining. (A) Low and (C) high 
magnification of Wt1fl/+;Pod-Cre  control kidney sections. (A) Only sporadic apoptotic cells (brown staining) 
are present in the outer renal cortex (oc). (C) No apoptotic cells are observable in glomeruli. (B) Low and (D) 
high magnification of Wt1fl/fl;Pod-Cre kidney sections. (B) Strongly enhanced apoptosis is detectable in the 
entire renal cortex. (D) Detached glomerular podocytes are mainly affected by apoptosis (arrows). oc, outer 
renal cortex; ic, inner renal cortex; m, medulla. 
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seemed to be intact; the loss of foot processes and associated slit diaphragms most 
probably rendered affected glomeruli incapable of filtration. 
 
3.2.7 Summary 
The findings presented above suggest that Wt1 deletion in developing podocytes of late 
developmental stages resulted primarily in structural changes in the form of widespread 
foot process effacement, which were followed by degeneration and apoptosis of 
podocytes. This was accompanied by the decay of entire glomeruli resulting in the 
dramatic reduction of overall glomerular number. Alongside with the degeneration of the 
glomerular filtration apparatus proximal convoluted tubules were strongly reduced as 
well. Since kidney function could no longer be maintained Wt1fl/fl;Pod-Cre mice did not 
produce urine and died rapidly after birth.  
3.3 Podocyte-specific Wt1 knock-out in adult mice 
3.3.1 Generation of inducible podocyte-specific Wt1 knock-out mice 
To generate the inducible podocyte-specific Wt1 knock-out mouse the loxP/Cre system 
was used in combination with elements originally derived from the Tn10 tetracycline-
Fig. 11. Ultrastructural analysis of newborn Wt1fl/fl;Pod-Cre and control kidneys. (A) Electron 
microscopy of a Wt1fl/+;Pod-Cre kidney section showing single glomerulus (GL) and convoluted proximal 
tubulus (PT) of normal appearance. (C) High magnification indentifies podocytes (P) with normal foot 
processes (arrows). (B) Section of a Wt1fl/fl;Pod-Cre kidney depicting a glomerulus in which one capillary 
vessel deprived of surrounding podocytes (arrow) can be seen. Proteinaceous material (asterisks) is 
emanating into the Bowman’s space. Protein casts are also found in dilated tubulus adjacent to the 
glomerulus (GL). (D) High magnification of a Wt1fl/fl;Pod-Cre kidney section reveals widespread foot process 
effacement (arrowheads). GL, glomerulus; PT, proximal convoluted tubulus. 
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resistance operon of Escherichia coli. In principle, gene expression from this operon is 
controlled by an operator sequence (tetO) to which a transcriptional repressor (TetR) is 
constantly bound. Association of the drug tetracycline with TetR leads to the dissociation 
of the repressor from the operator sequence and, consequently, to the initiation of gene 
expression.125  
Systems are now available, in which the Tet-repressor has been converted into a 
transcriptional activator (rtTA) by fusion to transcription activation domains. This 
transactivator can bind to and activate its cognate operator sequence exclusively in 
presence of the tetracycline-derivate doxycycline (anhydrotetracycline)126,127. A particular 
mouse line (Podocin-rtTA) allows podocyte-specific rtTA expression under control of the 
above described 2.5 kb NPHS2 promoter fragment107. In addition, mice are available where 
Cre expression is governed by elements consisting of an array of tetO sequences fused to 
minimal promoters (Ptet). These regulatory elements are strictly responsive to doxycycline-
activated transcriptional activators (rtTA)128, 129. The LC-1 mouse line used here features a bi-
directional Ptet element (Ptetbi-1) controlling both Cre and luciferase expression at the same 
time. The transgene is integrated into the mouse LC-1 locus allowing tight transcriptional 
control and low background expression112. 
The two mouse lines were crossed into the Wt1flox background to yield the inducible 
podocyte-specific Wt1 knock-out mouse, Wt1fl/fl;Podocin-rtTA;LC-1 (hereafter termed iWt1-
KO), and respective control animals, Wt1fl/+;Podocin-rtTA;LC-1 and Wt1fl/fl;LC-1. 
3.3.2 Cre expression controlled by the Podocin-rtTA/LC-1 system is podocyte-specific 
In order to prove that the Podocin-rtTA/LC-1 system ensures podocyte restricted Cre 
expression a triple heterozygous mouse line was established that harbors a Rosa26-LacZ 
reporter allele in addition to the Podocin-rtTA and LC-1 transgenes. Briefly, the Rosa26-LacZ 
reporter construct expresses the E. coli lacZ gene under control of a constitutively active 
promoter. However, transcription is inhibited by a stop cassette that is flanked by loxP 
sites. Only in cells synthesizing Cre-recombinase the stop cassette is removed by loxP 
recombination enabling lacZ expression to occur113. Presence of the respective gene 
product, beta-galactosidase, can be detected on tissue sections by adding the enzymes’ 
substrate, X-Gal. The substrate is converted into a product of blue color. 
To induce Cre expression 2 month old triple heterozygous mice (Rosa26-LacZ;Podocin-
rtTA;LC-1) were provided with 2 mg/ml doxycycline in the drinking water for 7 days. Age 
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matched control mice lacking the LC-1 transgene (Rosa26-LacZ;Podocin-rtTA) were treated 
accordingly. X-Gal staining of kidney sections revealed that Cre-recombinase was 
exclusively synthesized in glomerular podocytes of triple transgenic mice (Fig. 12 B, D) and 
entirely absent from control mice (Fig. 12 A, C). Thus, the Podocin-rtTA/LC-1 system is 
indeed suitable to drive Cre expression in a podocyte-restricted and inducible manner.  
 
3.3.3 Adult doxycycline-induced iWt1-KO mice develop massive proteinuria, but 
display only subtle kidney pathologies 
iWt1-KO and control mice (Wt1fl/+;Podocin-rtTA;LC-1) with a minimum age of 2 months were 
provided with drinking water supplemented with 2mg/ml doxycycline. Proteinuria, being 
the first sign for damages in the kidney’s filtration apparatus, was monitored. After five to 
seven days of continuous doxycycline application, iWt1-KO mice developed massive 
proteinuria. Control mice exhibited only physiological levels of urine protein content (Fig. 
13 A) showing that doxycycline does not cause proteinuria by itself.  
To determine the daily amount of protein excreted, urine of mice that had been induced 
for 7 days was gathered over 24 hours. Subsequent analyses revealed total protein 
Fig. 12. Analysis of Cre activity using a Rosa26-LacZ reporter mouse line. Mice were supplied with 
doxycycline for 7 days before kidneys were harvested and sectioned. 10 µm cryo sections were X-Gal 
treated and counter stained with eosin. (A), (C) Kidneys of control mice lacking the LC1 (Cre) transgene, but 
harboring both the Rosa26-LacZ reporter and the Podocin-rtTA construct exhibit no blue staining. (B), (C) In 
Rosa26-LacZ;Podocin-rtTA;LC-1 animals Cre activity was only detectable in glomerular podocytes and not in 
any other renal cell population or structure. (C) and (D) being higher magnifications of (A) and (B), 
respectively. Glomeruli are termed GL or are otherwise indicated by arrows. 
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concentrations between 2.7 µg/µl (Vtotal/24 h 350 µl) and 18.9 µg/µl (Vtotal/24 h 400 µl) in the 
urine of iWt1-KO mice compared to concentrations between 0.1 µg/µl (Vtotal/24 h 750 µl) and 
0.3 µg/µl (Vtotal/24 h 150 µl) of control animals. This effect was sex independent: the extent of 
proteinuria was similar in mice of both sexes. 
 
Fig. 13. Phenotype analysis of adult iWt1-KO mice after podocyte-specific Wt1 inactivation (A) 
Denaturing polyacrylamide gel loaded with 1 µl urine of three different iWt1-KO mice and the same number 
of control (Wt1fl/+;Podocin-rtTA;LC-1) animals treated with 2 mg/ml doxycycline for 6 days. 3 µg of bovine 
serum albumin (BSA) were loaded as standard. Coomassie Brilliant Blue staining revealed that iWt1-KO mice 
had developed proteinuria. (B) PCR on genomic DNA from kidneys of three different iWT1-KO and control 
(Wt1fl/fl;LC-1) mice previously treated with 2 mg/ml doxycycline for 6 days. The PCR product specific for the 
deleted Wt1 locus (Wt1Δ) was exclusively amplified from iWt1-KO kidney DNA. (C) PAS stained 5 µm paraffin 
section of a Wt1fl/+;Podocin-rtTA;LC-1 control kidney showing normal kidney tissue. (E) Normal glomerulus of 
the section depicted in (C). (D) iWt1-KO kidney paraffin section after PAS staining; the tissue appears normal 
except for dilated tubuli containing proteinaceous material (strong red staining). (F) Single glomerulus with 
hypertrophied Bowman’s Capsule (arrowhead) and vacuolized pariethal epithelial cells (PEC, arrows). All 
mice used for histology had been induced with 2 mg/ml doxycycline until iWt1-KO animals developed 
proteinuria (6 days). 
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By PCR on total kidney DNA it was confirmed that Wt1 was deleted in kidneys of 
doxycycline-treated iWt1-KO mice suffering from proteinuria (Fig. 13 B). In induced control 
animals lacking the Podocin-rtTA transgene (Wt1fl/fl;LC-1) Wt1 deletion could not be 
detected. This proves that the Cre expression system employed here is strictly regulated by 
doxycycline-activated rtTA and does not display background expression in absence of the 
transactivator (Fig. 13 B).  
Apart from massive proteinuria, induced iWT1-KO mice appeared normal and healthy. The 
body cavity was free of fluid; signs of edema or ascites were not observed. Kidneys of 
knock-out and control animals were comparable in terms of appearance, size and weight. 
In PAS stained kidney sections no gross abnormalities were found with one exception: 
dilated tubules filled with proteinaceous material were frequently present (Fig. 13 D, 
asterisks). The latter were never observed in control animals (Fig. 13 B, C).  
A minor number of iWt1-KO glomeruli displayed phenotypic changes primarily affecting 
pariethal epithelial cells (PEC’s) of the Bowman’s Capsule. Here the entire PEC layer was 
thickened and interspersed with strongly vacuolized cells (Fig. 13 F, arrows). Also 
podocytes were sometimes hypertrophied and vacuolized in these cases. 
3.3.4 The reduction of Wt1 protein levels varies strongly in kidneys of iWt1-KO mice 
After having shown that Wt1 was deleted upon induction of Cre expression in iWt1-KO 
kidneys it was necessary to analyze whether Wt1 protein levels were also affected in 
glomerular podocytes. Therefore, co-immunohistochemistry was performed using an 
antibody against the podocyte/glomerular marker podocin in combination with a Wt1 C-
terminal antibody. Kidneys from iWt1-KO mice and Wt1fl/+;Podocin-rtTA;LC-1 controls were 
harvested when proteinuria was diagnosed in the iWt1-KO cohort. Interestingly, in iWt1-KO 
mice Wt1 protein was still detectable in a number of glomeruli and the extent of overall 
reduction varied strongly in kidneys of different individuals. In three iWt1-KO animals the 
number of Wt1-negative glomeruli in relation to the total glomerular number was 
determined on the basis of five kidney sections per individual. In 11.8%, 24.3% and 69% of 
all glomeruli Wt1 was not detectable. On sections of control animals no Wt1-negative 
glomeruli were observed. Obviously, the reduction of Wt1 protein levels in a small number 
of glomeruli is sufficient to cause proteinuria. In Fig. 14 the immunohistochemistry results 
are depicted showing representative examples for Wt1-positive and negative glomeruli in 
iWt1-KO kidneys. 
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3.3.5 Podocytes of adult iWt1-KO mice display widespread loss of foot processes 
Kidneys from induced, proteinuria-positive iWt1-KO mice were subjected to electron 
microscopy based ultra-structural analyses. It was found that podocytes of a considerable 
number of glomeruli exhibited widespread loss of foot processes and slit diaphragms, 
respectively (Fig. 15 B and D, arrows), as observed in constitutive podocyte-specific Wt1 
knock-out kidneys. Furthermore, the podocyte-layer as well as the endothelium appeared 
abnormally distant from the glomerular basement membrane (GBM) (Fig. 15 D). In rare 
cases also other structural anomalies, such as spider like foot processes, could be noticed 
in kidney sections of iWt1-KO animals. However, pathological changes were not present in 
all glomeruli or all podocytes of a given glomerulus. In a number of cases podocytes had 
wild type appearance. Nevertheless, the pathologies detected in iWT1-KO mice were never 
observed in Wt1fl/+;Podocin-rtTA;LC-1 control kidneys (Fig.15 A and C) and are thus likely to 
be the cause of proteinuria.  
To analyze a possible role of Wt1 in the maintenance of the functional integrity of the 
glomerular basement membrane (GBM) polyethylenimine (PEI) staining130 was performed. 
PEI is a strongly cationic agent that binds to anionic sites present in the GBM. Since charge 
selectivity is assumed to be an important functional feature of the GBM any deviation in 
terms of charge might affect the overall renal filtration capacity62. In electron microscopic 
analyses PEI stained sites appear as dark dots within the GBM. As depicted in Fig. 15 C and 
D, the number of anionic sites in GBM’s of iWT1-KO (Fig. 15 D) and control mice (Fig. 15 C) 
Fig. 14. Presence of Wt1 protein after podocyte specific Wt1 inactivation in adult mice. Double-
immunohistochemistry on 10 µm cryo sections using Wt1- and podocin-specific antibodies. Wt1 is located 
in the nuclei of podocytes. Podocin is found in the cytoplasm of podocytes and was utilized as glomerular 
marker. Control and iWt1-KO mice were treated with 2 mg/ml doxycycline until iWt1-KO animals developed 
proteinuria. In glomeruli of control kidneys Wt1 protein levels were comparable (two examples are shown). 
iWt1-KO mice exhibited a heterogeneous picture: glomeruli lacking Wt1 protein (example 1) as well as 
glomeruli with unchanged Wt1 levels were found (example 2) in the same kidney.  
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were comparable. Thus, GBM charge seemed unaffected by the podocyte-specific 
inactivation of Wt1.  
 
3.3.6 Wt1 expression levels are significantly reduced in glomeruli of long-time 
induced iWT1-KO mice  
To explore the molecular causes of foot process effacement in iWt1-KO animals and to 
identify Wt1 target genes relevant for proper podocyte function microarray and real-time 
RT-PCR experiments were performed on the basis of both total kidney RNA and glomerular 
RNA of short-time induced (7 d) mice. However, no differences in Wt1 and overall gene 
expression levels between iWt1-KO, Wt1fl/+;Podocin-rtTA;LC-1 and Wt1fl/fl;LC-1 animals were 
detected (data not shown). For this reason preliminary long-time induction studies were 
conducted: iWt1-KO mice (n=2) and Wt1fl/fl;LC-1 control animals (n=2) were treated with 2 
mg/ml doxycycline for 2 months before glomeruli were isolated from the kidneys. 
Fig. 15. Ultrastructural analysis of adult induced iWt1-KO and control kidneys. Mice were treated with 
2 mg/ml doxycycline until iWt1-KO animals developed proteinuria; then kidneys were harvested. (A) 
Capillary vessel of a control glomerulus surrounded by podocytes with normally developed foot processes 
(arrow). (B) Podocytes loose foot processes after podocyte-specific inactivation of Wt1 in iWt1-KO mice 
(arrow). (C and D) Polyethylenimine (PEI) staining to analyze the charge of the glomerular basement 
membrane (GBM). PEI marks anionic sites in the GBM (black spots). No obvious charge differences between 
the GBM’s (asterisks) of induced iWt1-KO and control (Wt1fl/+;Podocin-rtTA;LC-1) glomeruli are detectable. (D) 
The distribution of PEI stained anionic sites within the GBM appears different compared to (C), since the 
GBM is irregularly shaped and in parts detached from podocytes and endothelium (arrowhead). The arrow 
in (C) marks a foot process and in (D) foot process deprived podocytes. 
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Subsequent real-time RT-PCR analyses on glomerular RNA/cDNA revealed that Wt1 
expression was significantly reduced by factor 8 in iWt1-KO glomeruli (Fig. 16). The 
expression of genes encoding foot process associated factors, Nphs2 (podocin) and Cd2ap, 
and the major constituent of the slit diaphragm, Nphs1 (nephrin), was found to be mildly 
reduced, between factor 1.5 and 2. Similarly, the podocyte marker gene Synpo 
(synaptopodin) was down-regulated by around factor 2 (Fig. 16).  
 
3.3.7 Two out of three iWt1-KO mice die after long-time induction; in surviving 
animals proteinuria decreases significantly 
In order to examine the consequences of long-time induction iWt1-KO mice and Wt1fl/fl;LC-1 
control animals were supplied with 2mg/ml doxycycline for 4 months. After 7 days of 
treatment, iWt1-KO mice developed proteinuria (Fig. 17, 7 d). The protein content, 
however, decreased significantly in the urine of all of these mice after 45 days of 
doxycycline administration (Fig. 17, 45 d). In one out of three iWt1-KO animals proteinuria 
could not be diagnosed after 125 days of treatment (Fig. 17, 125 d); in the two other mice 
the urine protein content increased again after this period of time (Fig. 17, 125 d, asterisks). 
Two days later both animals were found dead. The cause of death could not be elucidated. 
Fig. 16. Analysis of gene expression in glomeruli of long-time induced iWt1-KO animals. Both iWT1-KO 
(n=2) and Wt1fl/fl;LC-1 control animals (n=2) were treated with 2mg/ml doxycycline for 2 months. Expression 
of Wt1, Nphs1, Nphs2, Synpo and Cd2ap was measured by real-time RT-PCR on glomerular RNA/cDNA and 
was normalized to tbp (TATA box binding protein). Gene expression levels of iWT1-KO glomeruli were 
determined in relation to those of control glomeruli, which were set as 1. Differences in gene expression are 
depicted as fold difference. A negative prefix indicates down-regulation of genes in iWt1-KO glomeruli. 
Data represent the means and standard deviations of two independent experiments, measured in 
triplicates. Wt1 was down-regulated by factor 8 in iWt1-KO glomeruli; expression of all other genes was 
slightly reduced by factor 1.5 to 2. 
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Also, the processes leading to the temporal reduction and/or complete regression of 
proteinuria remain to be analyzed.  
 
3.3.8 Summary 
It has been shown that the Podocin-rtTA/LC-1 system used to generate the inducible 
podocyte-specific Wt1 knock-out mouse (iWt1-KO) was suitable to ensure podocyte-
restricted and inducible Cre expression. After five to nine days of doxycycline-mediated 
induction, adult iWt1-KO animals developed proteinuria, which was accompanied by Wt1 
deletion. Subtle histological changes, mostly in the form of protein casts within the renal 
tubular system, were observed. On the protein level Wt1 was absent or reduced in a 
varying number of glomeruli of different individuals. Accordingly, podocyte-associated 
ultrastructural changes, namely foot process effacement, were diagnosed in a varying 
number of podocytes and glomeruli, respectively. Changes in gene expression were only 
detectable after long-time doxycycline treatment. Wt1 expression was clearly reduced; 
other podocyte marker genes were slightly down-regulated. After 4 months of continuous 
induction two out of three mice died, one mouse, however, recovered almost completely 
from proteinuria. 
Fig. 17. Proteinuria progression during long-time induction of iWt1-KO animals. Mice were 
continuously supplied with 2 mg/ml doxycycline; after 7, 45 and 125 days of treatment 1 µl urine of each 
mouse was loaded onto a denaturing polyacrylamide gel. 3 µg BSA were used as standard. The gels were 
stained with Coomassie Brilliant Blue. After 7 days of treatment all three iWt1-KO animals had developed 
proteinuria, which decreased in intensity after 45 days of doxycycline administration. In one of these mice 
(animal 1) the urine was nearly free of protein, in the two other mice (animals 2 and 3) urine protein 
concentrations increased again after 125 days of induction. Wt1fl/fl;LC-1 control mice never developed 
proteinuria. Asterisks indicate mice that died after 127 days of induction. 
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4 Discussion 
4.1 Wt1 is required for podocyte and glomerulus differentiation  
The general importance of Wt1 in kidney development and function is undoubted since 
mutations in the gene have been associated with renal glomerular pathologies found in 
patients with Denys-Drash (DDS), Frasier (FS) or WAGR syndrome27-29, 32-35, 40, 41. In addition, 
mice carrying DDS- or FS-associated Wt1 mutations recapitulated the kidney phenotypes 
characteristic for the respective syndrome42, 103, 104, 106. Analyses of constitutive Wt1 knock-
out mice demonstrated that initiation of kidney development depends on Wt1 and that 
deletion of the gene results in renal agenesis59. The involvement of Wt1 in later renal 
developmental stages, such as nephron induction and glomerular differentiation, 
however, has not been supported by comparable in vivo data. A possible role of Wt1 in 
processes affecting the differentiation and maturation of the glomerulus has only been 
deduced from in vitro data suggesting a dependence of Vegfa expression and Pax2 down-
regulation on Wt1 (REFS 23, 26). But this and other functions could not be addressed in vivo 
due to the lack of suitable animal models. For this reason a mouse model has been 
generated in this work that enabled the knock-out of Wt1 specifically in podocyte 
precursor cells of the S-shaped body. Mice with the knock-out genotype (Wt1fl/fl;Pod-Cre) 
were born, but died rapidly between 12 and 24 h after birth and did not produce urine 
(anuria). The kidneys were normal in size and weight, but displayed superficial 
hemorrhage. Kidney development was normal until around E18.5 and E19.5. From these 
stages on a gradual reduction in the number of glomeruli became evident. At the time of 
birth almost no glomeruli could be identified. The remaining glomeruli were markedly 
smaller and showed different levels of beginning disintegration. Capillary tufts, though 
accordingly smaller, exhibited no obvious structural defects or alterations. To confirm the 
absence of glomeruli, immunohistochemical analyses were performed using antibodies 
against Wt1 and two other marker proteins, all present in maturing podocytes. The two 
markers analyzed have not been reported to be targets of Wt1 and are differently 
distributed within the cell; synaptopodin is an actin-associated protein, localized in the 
cytoplasm of the podocyte cell body and in primary and secondary processes100, whereas 
podocin is located at the cell membrane of podocyte foot processes and is coupled to the 
insertion site of the slit diaphragm. Wt1 was only detectable in the outer renal cortex, 
where mesenchymal cells and nephron pre-cursor structures of early developmental 
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stages reside. From the inner renal cortex, where glomeruli are normally located, Wt1 was 
absent. The same was true for the two additional podocyte marker proteins. These results, 
alone, only demonstrated the absence of podocytes from the inner renal cortex or loss of 
marker gene expression within these cells. In combination with the histological findings, 
however, these data clearly implicated a loss or strong reduction in the number of 
glomeruli as a consequence of Wt1 deletion. Still, to fully prove that glomeruli are indeed 
absent from the kidney cortex it would be necessary to investigate the presence of the two 
other cell populations constituting the glomerulus, mesangial and endothelial cells.  
The histological examinations revealed not only the loss of maturing glomeruli but also a 
significant reduction in the number of proximal tubuli. It is conceivable that this is a direct 
consequence of the degeneration and resulting physical absence of glomeruli, to which 
the proximal tubuli are directly connected. A rather hypothetical explanation would 
require the excretion of factors necessary for the differentiation or maintenance of the 
tubular epithelium by glomerular cells. In this case degeneration of glomeruli would also 
lead to the loss or de-differentiation of tubular structures. However, such paracrine 
interactions between these two nephron components, glomeruli and tubuli, have not yet 
been reported.  
The remaining proximal tubuli were collapsed, most probably due to the absence of urine. 
Interestingly, other visible tubular compartments including distal tubuli seemed to be 
unaffected, except that in some cases they, too, were found to be collapsed. A detailed 
immunohistochemical analysis of the tubular apparatus using antibodies against marker 
proteins of the different tubular segments was not conducted, but would be necessary to 
determine precisely, which of the segments are lost or regressing.  
Ultra structural analyses of residual glomeruli of Wt1fl/fl;Pod-Cre kidneys revealed 
pathological changes predominantly affecting podocytes; the most obvious phenotype 
observed was global foot process effacement and loss of the slit diaphragm as a 
consequence. In general, these structural changes would result in severe glomerular 
filtration defects with proteinuria as the major symptom. However, it seems that the 
observed anomalies represent only a very early phenotype or the onset of a rapidly 
progressing degenerative process. A next step might involve the detachment of 
podocytes, which was sometimes observed in electron microscopy: capillary vessels were 
found to be deprived of podocytes and glomerular basement membrane. Histological 
analyses confirmed the presence of detached cells within the Bowman’s space of residual 
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glomeruli and TUNEL assays revealed that these cells underwent programmed cell death. 
Thus, it appears that Wt1 deletion leads to structural changes in podocytes, which, in turn, 
result in the detachment and degeneration of these cells. The loss of a critical number of 
podocytes seems to be followed by the disintegration of the entire glomerulus. The 
significant reduction in the number of glomeruli, as observed in newborn Wt1fl/fl;Pod-Cre 
mice, is ultimately responsible for the impairment of kidney function. During embryonic 
development the fetal blood is filtered by the mother. At birth, however, the kidney defect 
becomes apparent and results in the early postnatal death of affected mice. Interestingly, 
none of the Wt1fl/+;Pod-Cre animals have developed any signs of kidney pathologies so far. 
Even after a follow-up period of up to one year these mice were free of obvious symptoms 
or kidney related diseases. It appears that Wt1 haploinsufficiency does not interfere with 
proper podocyte development and function. 
 
Our findings are supported by a recent publication of Jia et al. The authors could show that 
podocyte ablation during murine nephrogenesis leads to severe abnormalities of 
glomeruli and proximal tubuli comparable to those observed in Wt1fl/fl;Pod-Cre mice. To 
specifically disrupt developing podocytes in vivo a podocyte-specific Cre transgene 
(Podocin-Cre) was used to direct the production of diphtheria toxin A (DTA) directly within 
this cell population131. Transgenic mice phenocopied Wt1fl/fl;Pod-Cre animals and provided 
further prove that podocytes are indeed essential for glomerulus and nephron 
differentiation. The study indirectly emphasizes the significance of Wt1 in these processes, 
since Wt1 deletion results in the degeneration of podocytes as shown in this work. 
4.2 Wt1-associated podocyte defects result in kidney failure in patients and 
mice 
In this work it was demonstrated that Wt1 is an essential factor for podocyte differentiation 
and function. Moreover, evidence was provided that loss of podocytes leads to the 
degeneration of glomeruli, which, in turn, seems to interfere with nephron development 
and/or maintenance in general. Further prove for the important role of Wt1 in podocytes 
and glomeruli had been gained by analyses of patients and mice with heterozygous 
WT1/Wt1 point mutations. Diseases caused by these mutations are the Denys-Drash 
(DDS)32 and Frasier syndrome (FS)40. Patients suffering from Denys-Drash syndrome are 
normally free of symptoms at birth, but rapidly develop nephrotic syndrome before the 
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age of 2 years132. Nephrotic syndrome is characterized by strong proteinuria, 
hypoalbuminemia and peripheral edema. DDS patients commonly progress to end-stage 
renal failure before the age of 4. Their kidneys exhibit diffuse mesangial 
glomerulosclerosis, which is characterized by an expansion of the mesangial matrix and 
sometimes mesangial proliferation. The resulting sclerosis (or scarring) in combination 
with podocyte defects and podocyte loss leads to impairment of glomerular function. The 
term “diffuse” refers to the fact that all or most glomeruli of a given kidney are affected. At 
late stages of the disease sclerotic lesions are also observable in proximal tubuli of DDS 
kidneys. Podocytes are hypertrophied and vacuolized61. DDS mouse models greatly 
phenocopied patients: animals with a truncating Wt1 mutation at codon 396 were 
asymptomatic at birth, but developed progressive focal segmental glomerulosclerosis 4 to 
8 months later. In focal segmental glomerulosclerosis sclerotic lesions are only present in 
parts (segmental) of some (focal) glomeruli. The milder kidney defect was probably due to 
the use of chimeric mice with a low expression level of the mutant transgene. Only one 
heterozygous mouse was obtained; it was sterile and developed diffuse mesangial 
sclerosis 8 months after birth103. Introduction of the most common DDS-associated WT1 
mutation (R394W) in mice resulted in the severe kidney pathologies characteristic for the 
syndrome, but this greatly depended on the mouse genetic background. Heterozygous 
animals in an MF1 background died 5 months after birth from end stage renal failure 
caused by diffuse mesangial sclerosis. Podocytes displayed widespread foot processes 
effacement.106 Homozygous DDS mutants were embryonically lethal. It is still discussed 
why the mutation in only one Wt1 allele result in disease. DDS-associated WT1 mutations 
are assumed to be dominant-negative: one affected allele would therefore be sufficient to 
reduce the amount of functional Wt1 protein significantly36-39. And this, most likely, causes 
the severe kidney phenotype observed in patients and mice. However, pathological 
changes can first be identified in the mature kidney. Thus, it seems that even a strong 
reduction in functional WT1 protein levels does not interfere with kidney development, 
but causes disease in the mature or maturing kidney. 
In patients with Frasier syndrome the Wt1(+KTS)/(-KTS) ratio is imbalanced due to 
heterozygous point mutations in the alternative splice donor site of intron 9 (REF. 40). At 
birth those patients do not show any obvious kidney pathologies, but, in the majority of 
cases, develop proteinuria before 7 years of age. It increases progressively leading to 
nephrotic syndrome and slowly to end-stage renal failure. Renal biopsies mostly reveal 
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focal segmental glomerulosclerosis61. In a corresponding mouse model only the (–KTS) 
isoform is expressed from one allele, due to a mutation in the alternative splice donor site 
at the end of exon 9. Since both isoforms were still expressed from the remaining wild-type 
allele, the introduced mutation led to the FS typical imbalance of the (+KTS)/(-KTS) ratio. 
70% of these mice developed proteinuria 2 to 3 months after birth and died from renal 
insufficiency. Kidneys displayed focal segmental or diffuse mesangial sclerosis; glomerular 
and tubular numbers were unaffected.42 When both alleles were mutated and only the (-
KTS) isoform was present defects comparable to those in Wt1fl/fl;Pod-Cre animals were 
observed: mice were born, but died 24 h after birth. The bladders were found to be empty 
and kidneys were hemorrhagic. Podocytes lost foot processes. But the number of 
glomeruli and proximal tubuli remained unaffected. It was reasoned that the (+KTS) 
isoform is important for the development of the podocyte architecture.  
Total ablation of the (–KTS) isoform, leaving only (+KTS) expression, resulted in a similarly 
severe kidney phenotype leading to early postnatal death. Interestingly, in this case also a 
strong reduction in glomerular number was observed and supported by the finding that 
synaptopodin was entirely absent from the renal cortex. In Wt1fl/fl;Pod-Cre mice a similar 
defect was observed. One might speculate that Wt1(-KTS) is necessary for development 
and differentiation of podocytes and glomeruli, respectively, whereas the (+KTS) variant is 
needed to build up the unique podocyte specific structure. Ablation of both variants in late 
stage podocyte precursors, thus, leads to structural changes and de-differentiation of 
podocytes, as observed in podocyte-specific Wt1-null animals animals. In kidneys of (–KTS) 
ablated mice the decrease in glomerular number was accompanied by a reduction in the 
number of proximal convoluted tubuli42. A phenomenon also diagnosed in Wt1fl/fl;Pod-Cre 
animals. Again, it is tempting to speculate that factors derived from the glomerulus might 
stimulate the growth or maintenance of the tubular epithelium. 
That overall reduction in Wt1 expression levels leads to comparable defects as observed in 
mutant mice or animals with Wt1(+KTS)/(-KTS) imbalance was demonstrated in a mouse 
model that aimed to “rescue” Wt1 knock-out mice. By introduction of a YAC harboring the 
human WT1 gene into the genome of Wt1-/- mice wild type WT1 expression could be 
restored by 62 to 70%. Mice were born and had developed kidneys. Between 10 days and 6 
weeks proteinuria was detected that was caused by global mesangial sclerosis and, 
depending on the WT1 expression level, crescentic glomerulonephritis102. The latter is 
caused by severe damages of the renal filtration barrier and characterized by the formation 
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of crescent shaped scars within the glomerulus. Crescent formation results from (1) the 
leakage of fibrin and other plasma proteins into the Bowman’s space, (2) inflammatory 
processes and (3) the proliferation of pariethal epithelial cells. Both diffuse mesangial 
sclerosis and crescentic glomerulonephritis rapidly progress into end-stage renal failure 
from which the “rescued” animals eventually died102.  
As illustrated, Wt1 mutations and reduced Wt1 expression levels almost always result in 
glomerulosclerosis in humans and mice. Studies on the genetic basis of familial and 
sporadic focal segmental glomerulosclerosis (FSGS) have led to the identification of several 
factors in addition to WT1 that might be responsible for the disease. These genes include 
NPHS1 (nephrin) and NPHS2 (podocin), both of which code for slit diaphragm proteins. 
Furthermore, the gene coding for the cytoskeletal protein alpha-actinin-4, ACTN4, and 
TRPC6, which encodes a cation channel, have been implicated in FSGS etiology. All these 
factors are expressed in podocytes and most of which are necessary for the maintenance 
of the renal filtration barrier. Thus, this form of glomerulosclerosis is a podocytopathy (for 
reviews see (REFS. 133-135). The causes of mesangial sclerosis are not well understood. But 
it seems likely that podocyte defects are also responsible for mesangial proliferation and 
mesangial matrix expansion: damages of podocytes might lead to the destabilization of 
the glomerulus against the strong hydrostatic forces in capillary vessels. As a response, 
mesangial cells might be stimulated to increase mesangial matrix synthesis and/or to 
proliferate.  
Overall, these studies prove two points: (1) Podocytes are essential for glomerular integrity 
and function. (2) Wt1 is essential for the maintenance of podocyte structure and thereby 
indispensable for glomerular and kidney function in general. The podocyte-specific Wt1 
knock-out mouse model presented in this work provides further evidence for these 
findings. It also proved that total Wt1 inactivation exclusively in podocytes results in a 
more severe phenotype than global reduction of functional Wt1. Instead of post-natal 
glomerulosclerosis Wt1fl/fl;Pod-Cre animals had lost a high proportion of glomeruli already 
shortly before birth and died perinatally. Similarly, total ablation of the Wt1(-KTS) or 
Wt1(+KTS) isoforms accounted for a more severe phenotype than Wt1 mutation or 
reduced expression.  
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4.3 Wt1 is a transcriptional regulator of both “structural” and “developmental” 
genes in podocytes  
The analysis of Wt1 target genes has proven to be difficult in Wt1fl/fl;Pod-Cre mice. 
Expression of glomerulus/podocyte specific genes, including nephrin and synaptopodin, 
appeared to be downregulated or lost simply because the structures they are normally 
expressed in were absent or reduced in number. On the other hand factors like Pax2 and 
Wt1 itself are highly expressed in the metanephric mesenchyme and early nephron 
precursor cells; changes of expression levels in podocytes, which represent a minor cell 
population within the kidney, might therefore not be detectable. However, several factors 
with implications in podocyte development and function have been discussed in the 
literature to be transcriptional targets of Wt1: (1) Pax2 is highly expressed in the induced 
metanephric mesenchyme, but is abruptly downregulated in developing nephrons136. It is 
believed that Pax2 induces Wt1 expression and that Wt1 in turn negatively regulates Pax2 
(REFS. 23, 137). Failure to repress Pax2 in developing nephrons leads to severe developmental 
defects, such as reduced nephron number85. Ectopic expression of the gene in podocytes 
resulted in end stage renal failure of affected animals86. Interestingly, activation of Pax2 in 
adult mice led to the downregulation of Wt1 and nephrin and ultimately to the 
dedifferentiation of podocytes86. On the other hand, Pax2 was found to be upregulated in 
sclerotic glomeruli of Denys-Drash mice with a Wt1 mutation in codon 396 (REF. 104). 
However, it was only upregulated in globally sclerotic kidneys; reexpression of Pax2 might 
thus be a consequence of disease progression and not its cause. (2) Vegfa (vascular 
endothelial growth factor a) has been reported to be positively regulated by Wt1. It is 
expressed in podocyte precursor cells and has been shown to be necessary for the 
migration of endothelial cells into the S-shaped body; a process that is of vital importance 
for further nephron development26, 84. So far no in vivo evidence has been provided to 
support a possible role of Wt1 in the regulation of Vegfa. (3) Genes encoding growth 
factors: Wt1 is assumed to be a transcriptional repressor of growth factors138. In line with 
this hypothesis PDGF-A (platelet derived growth factor A) and TGF-β1 (transforming growth 
factor beta1), both are discussed as direct Wt1 target genes, were upregulated in glomeruli 
of DDS patients18, 25, 139. In DDS mice with the most common Wt1 point mutation in codon 
394 Tgf-β1 and Igf-1 (insulin-like growth factor 1) expression was enhanced106. Yet, in none 
of the cases inappropriate proliferation was detectable in glomeruli. Whether growth 
factors are involved in or upregulated as a consequence of podocyte defects associated 
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with Wt1 mutations remains to be proven. In Wt1fl/fl;Pod-Cre glomeruli no indications for 
increased proliferation were observed. (4) Nphs1 was shown to be a direct target of Wt1 in 
vitro22. Its gene product nephrin is the major slit diaphragm component140. Mutations in the 
gene are associated with focal segmental glomerulosclerosis87. Total knock-out of the gene 
led to severe podocyte defects including loss of slit-diaphragms and foot-processes92. Mice 
exhibited strong proteinuria and died 24 h after birth. Regression of glomeruli or tubular 
compartments, as seen in Wt1fl/fl;Pod-Cre animals, was never observed. In mice with 
reduced Wt1 expression Nphs1 was also found to be downregulated102. (5) Podxl codes for 
podocalyxin, another component of the slit diaphragm, and has been reported to be 
directly activated by Wt1 (REFS. 21, 140). Deletion of the gene in mice results in podocyte 
defects comparable to those caused by inactivation of nephrin or other slit diaphragm 
associated factors94. In mice with reduced Wt1 expression podxl was also downregulated102. 
(6) Amphiregulin (Areg) is a member of the epidermal growth factor family. Areg is 
coexpressed with Wt1 during kidney development and is positively regulated by Wt1 in 
vitro20. Interestingly, total knock-out of the gene produced no obvious kidney 
pathologies141. The role of amphiregulin in podocyte biology remains to be determined. 
The expression of other podocyte-relevant factors such as podocin, alpha-actinin-4 and 
Cd2ap was altered in sclerotic glomeruli of DDS mouse models104, 106. But this could not be 
directly linked to Wt1. It is likely that glomerular defects result in a generally altered gene 
expression profile; the changes in expression of podocyte-associated genes might simply 
be a consequence of this possibility. 
However, considering the severity of the kidney defects in Wt1fl/fl;Pod-Cre animals and other 
mouse models it seems indeed likely that Wt1 is directly and/or indirectly involved in the 
regulation of several genes important for podocyte function. The wide spectrum of 
proposed Wt1 target genes, ranging from developmental factors such as Pax2 to structural 
factors like podocalyxin, reflects the versatility of Wt1 function and complicates its analysis 
at the same time.  
4.4 Wt1 is important for the maintenance of podocyte structure and function in 
adult mice 
Wt1 is expressed in podocytes throughout the life of mammalian organisms10. For this 
reason the gene has long been assumed to be important not only for development and 
differentiation, but also for the maintenance of this cell population. The fact that mutations 
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in Wt1 can result in podocyte defects, as demonstrated above, has supported this 
assumption. But a podocyte restricted Wt1 knock-out in adult mice has not yet been 
conducted. In the presented work an inducible Cre/loxP based strategy was followed to 
achieve exactly this. For that purpose, the doxycycline-inducible Podocin-rtTA/LC-1 Cre-
expression system was used in combination with the conditional Wt1 knock-out mouse. To 
prove podocyte-specificity of the Cre expression system, a compound reporter mouse line 
was generated harboring the following transgenes: a Rosa26-lacZ reporter element, the 
Cre expression construct, LC-1, and the Podocin-rtTA transgene. After Cre expression was 
induced by doxycycline administration for 7 days in 2 months old triple transgenic mice 
(Rosa26-lacZ/+;Podocin-rtTA/+;LC-1/+) Cre activity was detected exclusively in glomerular 
podocytes, not in other structures within the kidney. Although almost all glomeruli per 
kidney section were Cre positive, it appeared that only a proportion of podocytes showed 
Cre activity. This might be due to limited efficiency of the doxycycline mediated induction. 
Treatment with the drug over a longer period would probably increase the percentage of 
Cre positive podocytes. Other organs, including liver, bladder, gut, brain, spleen, gonads, 
heart, lung and stomach, were examined additionally, but displayed no signs of Cre 
activity. 
After having shown that the Podocin-rtTA/LC-1 system allowed podocyte restricted Cre 
expression the two transgenes were introduced into the Wt1fl/fl background giving rise to 
iWt1-KO mice. For all conducted analyses animals of at least two months of age were used 
to exclude developmental processes taking place in the kidneys. Furthermore, only age 
and sex matched animals were compared, so that possible age or sex related anatomical 
differences could not be misinterpreted as pathological phenotype.  
The most common indication of defects in the glomerular filtration apparatus is the 
appearance of high molecular proteins, such as albumin, in the urine142. Therefore, iWt1-KO 
and control mice were monitored for proteinuria after doxycycline treatment was started. 
By day 9 of treatment all examined iWt1-KO mice had developed massive proteinuria. In 
contrast, urine of Wt1fl/+;Podocin-rtTA;LC-1 animals remained free of protein, even after 6 
months of continuous doxycycline supply. Wt1 deletion was detected by PCR on whole 
kidney DNA in iWT1-KO mice and to a lower extend in heterozygous controls 
(Wt1fl/+;Podocin-rtTA;LC-1). In Wt1fl/fl;LC-1 mice, lacking the rtTA transgene, Wt1 was not 
deleted and proteinuria was not detected. These findings allowed the conclusion that 
proteinuria was a consequence of homozygous kidney/podocyte restricted Wt1 
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inactivation. Haploinsufficiency on the other hand seems not to interfere with normal 
kidney function. It has been reported recently that doxycycline itself can induce kidney 
defects143. The fact that Wt1fl/+;Podocin-rtTA;LC-1 control animals equally treated with 
doxycycline did not develop proteinuria or other obvious kidney defects excluded this 
possibility, however.  
Despite the high amounts of excreted albumin the anomalies detected with histological 
methods were surprisingly subtle. Beside a high frequency of dilated tubuli filled with high 
amounts of proteinaceous material no gross anatomical changes were diagnosed. Rarely, 
glomeruli displayed thickening of the pariethal epithelium and sporadic vacuolization of 
podocytes, which seemed to adhere to the Bowman’s capsule. Whether this was a sign for 
beginning glomerulosclerosis is not entirely clear. To address this, mice need to be 
induced and monitored for a longer time period. Overall, no obvious differences between 
kidney sections of doxycycline induced iWt1-KO, Wt1fl/+;Podocin-rtTA;LC-1 and Wt1fl/fl;LC-1 
animals could be identified, with the exceptions mentioned above. On the ultra structural 
level, however, one striking difference was observed: podocytes of iWt1-KO mice displayed 
foot-process effacement and, as a consequence, loss of the slit diaphragm (SD) in a focal, 
segmental distribution. Furthermore, the podocyte cell layer seemed to be detached from 
the underlying glomerular basement membrane (GBM), which displayed normal size and 
charge. The endothelium appeared intact, but was abnormally distant from the GBM. This 
indicated a partial disruption of the glomerular filtration apparatus, which is in turn likely 
to cause proteinuria. It has been demonstrated many times in human and mouse, that foot 
process effacement results in proteinuria61, 142. 
The fact that only a relatively small proportion of podocytes displayed foot-process 
effacement might again be explained with the limited efficiency of Cre activation and is in 
line with findings in the Rosa26-LacZ;Podocin-rtTA;LC-1 reporter mouse line. Doxycycline 
mediated induction for 6 to 8 days might be sufficient to cause proteinuria, but might not 
be enough to target the majority of podocytes. This was further supported by the 
observation that Wt1 protein was still detectable in a considerable, but varying number of 
glomeruli and podocytes, respectively. However, in all observed iWt1-KO mice Wt1 protein 
levels were at least moderately reduced. For this reason microarray studies were 
performed to identify Wt1 dependent factors important for the maintenance of the 
structural and functional features of podocytes. However, experiments using both total 
kidney RNA and RNA obtained from isolated glomeruli of induced iWt1-KO and Wt1fl/fl;LC-1 
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control mice failed to identify differentially expressed genes. Even Wt1 expression was 
comparable in knock-out and control animals. Thus, long-time experiments were 
conducted to induce Wt1 deletion in a higher proportion of podocytes. For this, mice were 
continuously induced with doxycycline and glomerular gene expression was analyzed by 
real-time qRT-PCR. After 2 months of treatment Wt1 was found to be down-regulated in 
glomeruli of iWt1-KO mice by factor 8 when compared to Wt1fl/fl;LC-1 controls. The 
expression of other podocyte specific factors including podocin (Nphs2), Cd2ap, 
synaptopodin and the known Wt1 target gene nephrin (Nphs1) was reduced between factor 
1.5 and 2. Technically the study has to be considered preliminary, since mouse cohorts 
were too small (n=2) to draw statistically valid conclusions. Furthermore, only podocyte 
marker genes were analyzed; podocyte-independent factors were not included. However, 
from the data obtained one might assume that Wt1 is important for the regulation of 
several key constituents of the podocyte; due to the mild changes in gene expression it 
seems likely that other factors are also involved in their regulation. Considering the 
podocyte defects observed it is conceivable that the cumulative down-regulation, 
however mild, of a number of genes relevant for the formation and maintenance of foot 
processes might eventually result in the degeneration of these structures. On the other 
hand it seems likely that other Wt1 target genes, including so far unknown factors, are 
necessary for the maintenance of podocyte architecture and function. To identify such 
factors in a large scale directly in podocytes a diploma student of our group, Claudia Lück, 
is currently working on a method to induce Wt1 deletion in isolated (primary) podocytes of 
adult conditional Wt1 knock-out mice (Wt1fl/fl). In collaboration with Frank Edenhofer in 
Bonn these primary podocytes will be transduced with a TAT-Cre fusion protein in vitro. 
Edenhofer and colleagues could show that Cre-recombinase fused to an HIV-TAT protein 
can be efficiently delivered into cells and that Cre-activity is not compromised by TAT144. 
Our own findings suggest high transduction rates and efficient Cre mediated loxP 
recombination when primary podocytes are used. Gene expression analyses will be 
performed with RNA sequencing techniques and might help to better understand the role 
of Wt1 in podocytes. 
 
An interesting new aspect of the presented mouse model was revealed by long-time 
induction experiments. It is based on the finding that the urine protein content of iWt1-KO 
mice gradually decreased, the longer the animals were treated with doxycycline. In one 
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out of three long-time induced iWt1-KO animals proteinuria was hardly detectable after 4 
months of doxycycline administration. In the two other mice urine protein levels dropped 
after induction for more than one month, but increased again to the initial levels. After 4 
months those animals suddenly died. It is not clear what causes this phenomenon: one 
possibility is that defective glomeruli simply degenerate. In this case urine protein levels 
would drop as long as intact glomeruli are still present. However, since mice are 
continuously treated with doxycycline more and more glomeruli develop defects leading 
again to an increase in protein levels. In two of three mice this was observed after 4 
months. Finally, constant glomerular degeneration would lead to kidney malfunction and 
most probably death. To confirm this hypothesis histological analyses have to be 
performed to prove glomerular degeneration, which was never observed in shortly 
induced animals. The model would not explain why one of the mice showed complete 
recovery.  
Another possible explanation is that tubular reabsorption of protein is increased in 
response to elevated levels in the ultrafiltrate. However, it has been shown that protein 
retrieval by the epithelium of proximal tubuli is rather inefficient142 and therefore unlikely 
to cope with the high amounts of protein in the urine of iWt1-KO mice. 
A more tempting speculation implicates regenerative processes leading to the 
replacement of defective podocytes and thereby to a reduction of proteinuria. Podocytes 
in the adult are incapable of replicative cell proliferation and it was assumed for many 
years that lost podocytes cannot be replaced. Recently, two publications showed that (1) a 
type of progenitor cells is present in the Bowman’s capsule with the potential to replace 
podocytes145 and (2) that pariethal epithelial cells (PEC) can migrate from the Bowman’s 
capsule into the vascular tuft and differentiate into podocytes146. However, these processes 
are rather slow, so that massive podocyte degeneration, as seen in nephrotic syndrome, 
cannot be compensated. But it is conceivable that the described regenerative mechanisms 
might mitigate the effects of podocyte loss to a certain extend and at least temporarily. It 
will be interesting to address these hypotheses in the future. 
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